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 1 
General Introduction 
 
Cofactor-containing metalloenzyme 
Metalloenzymes containing cofactors such as several heme derivatives, vitamin B12, F430 are responsible 
for the catalysis of essential reactions in organisms.  For example, horseradish peroxidase (HRP) and 
cytochrome P450cam, which contain iron protoporphyrin IX (heme b) as a cofactor, promote one-electron 
 
 
Figure 1.  (a) Chemical structure of iron protoporphyrin IX as a cofactor.  Structures of (b) horseradish 
peroxidase (PDB ID: 1H58) and (c) cytochrome P450cam (PDB ID: 2CPP).  (d) and (e) Representative 
reaction schemes catalyzed by HRP and P450cam.  (f) Chemical structure of methylcobalamin.  (g) 
Crystal structure of the cobalamin-binding domain of methionine synthase (PDB ID: 1BMT).  (h) 
Transmethylation catalyzed by methionine synthase. 
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oxidation of phenol derivatives and hydroxylation of camphor, respectively (Figure 1a–e).  These 
reactions are not readily carried out by conventional organic synthesis under mild conditions at ambient 
temperature and pressure in water.  HRP oxidizes phenol derivatives using hydrogen peroxide in 
organisms (Figure 1d).  The heme cofactor is coordinated with a histidine residue in the HRP matrix.1  
Cytochrome P450cam contains the same heme cofactor with a Fe–S(cys) coordination2 and mediates the 
regioselective hydroxylation of camphor using dioxygen in the protein matrix (Figure 1e).  Thus, the 
coordination environments control the reactivity of the heme cofactors and promote oxidation or 
hydroxylation reactions.   
On the other hand, methionine synthase is also a cofactor-dependent enzyme.  It contains 
methylcobalamin as an organometallic cofactor (Figure 1f,g) and catalyzes a methyl group transfer from 
N-methyltetrahydrofolate to homocysteine, generating methionine and tetrahydrofolate (Figure 1h).3  The 
cobalamin derivatives have been received much attention as an important cofactor not only from the field 
of coordination chemistry but also from the field of bioinorganic and bioorganometallic chemistry.3,4 
 
Cobalamin derivatives and the Co–C bond cleavages 
Methylcobalamin and adenosylcobalamin are known as organometallic cofactors in most living organisms 
(Figure 2a).4  Their precursor, cobalamin, is a cobalt complex with a corrin framework which is a 
tetrapyrrole ligand similar to a well-known porphyrin framework.  In contrast to porphyrin, corrin has 
four highly saturated pyrrole rings and smaller framework size due to lacking one of the meso carbon 
atoms and connecting the C1–C19 bond in the corrin framework (Figure 2b).  In addition, corrin acts as a 
monoanionic ligand compared to a dianionic ligand of porphyrin.  Furthermore, the cobalamin derivatives 
form an intramolecular coordination bond with a peripherally-attached 6,7-dimethylbenzimidazole (DMB) 
moiety at the 17-position of the framework, and the axial coordination stabilizes the Co–C bond of 
methylcobalamin (Figure 2a).5   
The cobalamin-dependent enzymes promote either homolytic or heterolytic cleavage of the Co–C 
bond of the cobalamin derivatives for their enzymatic reaction.6  For example, methylmalonyl CoA 
mutase promotes the homolysis of the Co–C bond of adenosylcobalamin to catalyze a radical 
rearrangement reaction (Figure 2c).  In contrast, methionine synthase promotes the heterolysis of the 
Co–C bond of methylcobalamin toward the transmethylation (Figure 1h and Figure 2d).  Thus, the 
protein matrices control the reactivity of the cobalamin derivatives, and the mechanism has been 
investigated.  In the case of homolysis, the cobalamin-dependent enzymes promote the dissociation of the 
Co–C bond by 109-fold.7  Theoretical study suggests that the axial coordination stabilizes the produced 
Co(II) species to promote the homolytic cleavage.7b  In contrast, it is reported that the enzymatic 
heterolysis of the Co–C bond is ca. 105-fold accelerated compared to the non-catalyzed reactions.8  
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However, the mechanism of the enzymatic heterolysis has never been completely clear and the X-ray 
crystal structure of the heterolysis product has been unavailable.9,10 
 
Figure 2.  Chemical structure of (a) cobalamin derivatives and (b) corrin and porphyrin frameworks.  (c) 
Homolytic and (d) heterolytic cleavages of the Co–C bonds in the cobalamin-dependent enzymes.  
 
 
Methionine synthase 
Cobalamin-dependent methionine synthase is widely found in Prokaryota and Eukaryota.3,11  The enzyme 
is a large modular protein (ca. 146 kDa) with four distinct functional domains and one domain possesses 
cobalamin as a cofactor.  The X-ray crystal structure of the cobalamin-binding domain shows that 
cobalamin interacts with a histidine residue as an axial ligand and the DMB moiety is free from the cobalt 
ion (Figure 3a).12  In addition to the cobalamin-binding domain, two kinds of substrate-binding domains 
contain the binding sites for homocysteine and N-methyltetrahydrofolate, respectively.3  Moreover, the 
activation domain reduces Cob(II)alamin, which is produced by an undesired oxidation reaction during the 
enzymatic reaction, in order to regenerate Cob(I)alamin, and subsequently the Co(I) species is methylated 
using S-adenosylmethionine as a methyl group donor to reproduce methylcobalamin.3  The enzyme is 
responsible for the catalysis of transmethylation reaction, converting N-methyltetrahydrofolate and 
homocysteine to produce methionine and tetrahydrofolate.  The investigation of the enzymatic reaction 
reveals that the enzyme promotes two kinds of methyl group transfers in the catalytic cycle: (a) 
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methylation of cob(I)alamin by N-methyltetrahydrofolate as a methyl group donor, and (b) methionine 
synthesis by the reaction of homocysteine with the methylcobalamin intermediate (Figure 3b).3  However, 
the detailed mechanism of the transmethylations in the protein matrix and the crystal structure of the Co(I) 
species as an intermediate have not been understood completely.3,6,10   
 
 
Figure 3.  (a) Structures of the four domains of methionine synthase: cobalamin binding domain (PDB 
ID: 1BMT), two substrate-binding domains (PDB ID: 1Q8J) and activation domain (PDB ID: 1K7Y).  
Cobalamin is represented as sphere models.  (b) Plausible catalytic cycle of the transmethylation 
reactions observed in methionine synthase.   
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Cobalamin models 
As cobalamin model complexes, cobalt tetra- and di-dehydrocorrins have been prepared to understand the 
enzymatic reactions (Figure 4a,b).13,14  The former has four additional double bonds at the -position of 
the pyrrole rings in the framework compared to the corrin framework.  The Co(II)/Co(I)-redox potential 
of the cobalt complex is more positive than that of cobalamin.13  Thus, it is suggested that the Co(I) 
species of tetradehydrocorrin is stabler than that of cobalamin and less reactive for the formation of a 
Co–C bond by methyl iodide in organic solvents.  In contrast, cobalt didehydrocorrin, which has two 
additional double bonds at the -position of the pyrrole rings in the framework compared to the cobalamin 
framework,14 has a similar Co(II)/Co(I)-redox potential to cobinamide, which is a cobalamin analog 
without DMB moiety (Figure 4c).  The Co(I) species of cobalt didehydrocorrin is known to be more 
reactive for a methyl donor than that of cobalt tetradehydrocorrin.  The UV-vis spectra of the Co(I) and 
methylated Co(III) species of didehydrocorrin are similar to those of cobinamide.  The suitable model 
complexes of the cobalamin cofactor have been constructed,15 however, the report of the transmethylation 
by the cobalamin models was quite limited.9,16  In contrast, cobalt phthalocyanine is also a suitable model 
for cobalamin.  The transmethylation from methylated cobalt phthalocyanine to nucleophiles occurs 
because the Co(I) species acts as a good leaving group.16   
Cobalamin derivatives have been incorporated into hydrophobic environments, which mimic the 
protein matrices of the cobalamin-dependent enzymes.17,18  For example, a liposome or human serum 
albumin (HSA) including a hydrophobic cobalamin derivative (Figure 4d) was prepared as the 
enzyme-inspired models (Figure 4e,f).  In the former model, the alkylated hydrophobic cobalamin 
derivatives were noncovalently fixed in the bilayer membrane in an aqueous solution.17  In the latter 
model, the alkylated hydrophobic cobalamin derivatives also inserted into the protein hydrophobic 
environment of HSA, which is capable of introducing hydrophobic molecules in the protein matrix.18  
Both these models demonstrate that photo-irradiation induced homolysis of the Co–C bond and then 
rearrangement reactions occurred in the hydrophobic environment.  The models improved the radical 
rearrangement reactions via a homolytic cleavage of the Co–C bond of the cobalamin derivative in the 
hydrophobic environments.  However, the model systems require activation such as the irradiation to 
cleave the Co–C bonds, while the natural cobalamin-dependent enzymes mediate cleavages of the Co–C 
bonds under the dark condition.  In addition, the transmethylation reaction via heterolysis has not been 
reported in these models.  Furthermore, the axial ligation of the cobalt complex has been unclear due to 
the unregulated incorporation of the cobalamin derivative in the models.  Hence, construction of a 
cobalamin model with a well-defined coordination environment, replicating the protein matrix of the 
enzyme, is required to clarify the mechanism of the enzymatic transmethylation reactions and the role of 
the protein matrix of the complicated cobalamin-dependent enzymes.   
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Figure 4.  Chemical structures of (a) cobalt tetradehydrocorrin, (b) cobalt didehydrocorrin, (c) 
cobinamide and (d) hydrophobic cobalamin.  Schematic representation of cobalamin models incorporated 
into (e) liposome and (f) human serum albumin as the hydrophobic environments.   
 
 
Myoglobin reconstituted with an artificial cofactor 
Myoglobin, an oxygen carrier hemoprotein (ca. 17 kDa), contains heme as a cofactor.19  The heme 
cofactor is wedged in the heme pocket by the Fe–N(His93) coordination, hydrophobic contact of the heme 
with several nonpolar aliphatic and aromatic amino acid residues, and the formation of the salt bridge 
between the heme-propionate side chain and polar residues (Figure 5a).20  
To elucidate the oxygen binding mechanism and modify its function, the replacement of the heme 
cofactor with an artificial cofactor has been demonstrated for myoglobin.  The native heme cofactor is 
extracted by 2-butanone under an acidic condition to convert apomyoglobin (apoMb).21  Under a 
neutralized condition, an artificial cofactor is inserted into apomyoglobin to yield reconstituted myoglobin 
(rMb) (Figure 5b).22  A series of myoglobins reconstituted with artificial cofactors has been investigated 
by several research groups.  For example, myoglobin reconstituted with manganese porphycene, a 
constitutional isomer of porphyrin, demonstrates catalytic hydroxylation of a C(sp3)–H bond of 
ethylbenzene in the heme pocket.23  In addition, X-ray crystallography experiments reveal that the 
cofactor is coordinated with the axial His93 residue in the protein matrix.  Therefore, the 
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cofactor-substitution is a useful method for construction of an enzyme model in which the cofactor is 
coordinated with the axial histidine residue in the hydrophobic protein matrix.   
 
Figure 5.  (a) Crystal structure of native myoglobin (PDB ID: 1YMB) and chemical structure of the heme 
cofactor.  (b) Scheme of preparation of myoglobin reconstituted with an artificial cofactor.   
 
 
Strategy for an enzyme model of methionine synthase 
As an enzyme model of cobalamin dependent-methionine synthase, a cobalamin model complex with a 
simple protein matrix which provides a suitable coordination environment is constructed and investigated 
in this thesis (Figure 6).3,12  Apomyoglobin and cobalt tetradehydrocorrin (Co(TDHC)) are employed as a 
suitable model complex of cobalamin and a simple protein matrix having a similar coordination 
environment to the cobalamin binding domain of methionine synthase, respectively.13,22  Reconstitution 
of myoglobin with Co(TDHC) yields a hybrid protein, rMb(Co(TDHC)), as an enzyme model (Figure 6).  
The detailed investigation of rMb(Co(TDHC)) will contribute to understanding of coordination behavior of 
the cofactor in the protein matrix.   
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Figure 6.  Strategy for construction of the methionine synthase model using cobalt tetradehydrocorrin 
(Co(TDHC)) as a cobalamin model complex and apomyoglobin (apoMb) as a simple protein matrix, 
respectively. 
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Outline of this thesis 
 
The author constructed an enzyme model of cobalamin-dependent methionine synthase and X-ray crystal 
structures of the Co(II) and Co(I) species were demonstrated (chapter 1).  The formation of the Co–C 
bond and subsequent transmethylation were observed in the protein matrix (Chapter 2).  Aqua- and 
cyano-Co(III) species in the heme pocket were prepared and investigated to understand the coordination 
behavior of the native enzyme (chapter 3).    
 
Chapter 1:  Preparation of myoglobin reconstituted with cobalt corrinoid and X-ray 
crystal structures of the Co(II) and Co(I) species 
A conjugate between apomyoglobin and cobalt tetradehydrocorrin was prepared to replicate the 
coordination behavior of cobalamin in methionine synthase.  X-ray crystallography experiments reveal 
that the tetra-coordinated Co(I) species, CoI(TDHC), is formed through the cleavage of the axial 
Co–N(His93) ligation after the reduction of the penta-coordinated Co(II) cofactor in the heme pocket. 
 
Chapter 2:  Formation of a Co–C bond and subsequent transmethylation in 
myoglobin reconstituted with the cobalt corrinoid 
In the heme pocket, CoI(TDHC) is found to react with methyl iodide to form the methylated cobalt 
complex, although it is known that a similar nucleophilic reaction of a cobalt(I) tetradehydrocorrin 
complex does not proceed effectively in organic solvents.  Furthermore, the author observed a residue- 
and regio-selective transmethylation from the methylated complex to the Nε2 atom of the His64 imidazole 
ring in myoglobin at 25 °C over a period of 48 h.  The theoretical calculations provide a plausible 
reaction mechanism wherein the axial histidine ligation stabilizes the methylated cobalt complex and 
subsequent proximal histidine-flipping induces the transmethylation via heterolytic cleavage of the 
Co–CH3 bond in the hybrid model. 
 
Chapter 3:  Coordination behavior of aqua- and cyano-Co(III) corrinoids with the 
histidine-ligation in the myoglobin matrix 
Myoglobins reconstituted with aqua- and cyano-Co(III) tetradehydrocorrins were prepared as cobalamin 
models.  X-ray crystal structure analyses clearly reveal that the cobalt complexes form a 
hexa-coordinated structure with axial ligation by His93 and an exogenous molecule in the heme pocket.  
Acid titration, 13C NMR and IR data indicate that both axial bonds, Co–CN and Co–N(His), are weakened 
upon replacement of water with cyanide.  This finding is supported by DFT calculations. 
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Chapter 1 
Preparation of myoglobin reconstituted with cobalt corrinoid and X-ray crystal 
structures of the Co(II) and Co(I) species 
 
1-1.  Introduction 
Methionine synthase is responsible for the essential methylation of homocysteine to yield methionine.  It 
is known that the enzyme requires N5-methyltetrahydrofolate as a methyl group donor and that the methyl 
group transfer to homocysteine is promoted by a cobalamin cofactor, a vitamin B12-like cobalt corrinoid 
complex.1–4  The entire enzyme structure has a molecular weight of ca. 136 kDa and includes four 
domains.  The complexity of this enzyme system poses significant challenges with respect to the 
characterization of the entire structure.  The crystal structure of the cobalamin-binding domain of 
methionine synthase has been determined by Ludwig and co-workers, and it was found that the axial 
 
Figure 1-1.  Structure of holoproteins and cofactors.  (a) The crystal structure of the cobalamin-binding 
domain (PDB ID: 1BMT) of methionine synthase and the molecular structure of cobalamin.  (b) Crystal 
structure of horse heart myoglobin (PDB ID: 2V1K) and molecular structures of native heme and 
CoII(TDHC). Native heme is replaceable with CoII(TDHC) as a cobalamin model. 
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ligand of cobalamin is a protein-derived histidine residue and not the 6,7-dimethylbenzimidazole (DMB) 
moiety, which is peripherally-attached at the 17-position of the cobalamin framework, a base-off/His-on 
state (Figure 1-1a).5  In the catalytic cycle, two key intermediates have been proposed to exist transiently; 
(i) a highly nucleophilic tetra-coordinated Co(I) species known as cob(I)alamin and (ii) a methylated 
Co(III) species known as methylcobalamin.1–3  However, the structure of cob(I)alamin has never been 
determined directly.5,6  Herein, the author reports a hybrid model consisting of a cobalamin model 
complex with a suitable protein matrix to improve the our understanding of the formation of the 
intermediate with the axial ligand rearrangement in the protein.  The hybrid model for methionine 
synthase was constructed as follows (Figure 1-1b): First, horse heart apomyoglobin was used as a 
substitute protein matrix for the cobalamin-binding domain of methionine synthase.  It is a relatively 
small and well-known protein which provides a histidine residue as an axial ligand to the heme cofactor in 
the heme-binding pocket as well as the cobalamin-binding domain.  Second, a cobalt tetradehydrocorrin 
complex was designed as an artificial cofactor to mimic the cobalamin moiety because native cobalamin 
consists of a tetrapyrrole macrocyclic ligand known as a corrinoid.  Dolphin and co-workers synthesized 
a cobalt complex of 1,19-dimethyltetradehydrocorrin and detected the stable Co(I) species by UV-vis 
spectroscopy.6  This inspired us to insert such a complex into the apomyoglobin heme pocket to obtain 
ligation by the His93 residue which coordinates to the native heme iron of myoglobin.   
 
1-2.  Results and Discussion 
Preparation and characterization of the enzyme model 
The cobalt corrinoid complex, Co(TDHC) (TDHC = 
8,12-dicarboxyethyl-1,2,3,7,13,17,18,19-octamethyltetradehydrocorrin) (Figure 1-1b), was prepared as a 
model of cobalamin by cyclization of the corresponding biladiene-a,c dihydrobromide derivative in the 
presence of Co(OAc)2 (Scheme 1-1).7  Two methyl substituents at the C1- and C19-positions are on 
opposite faces of the corrinoid ring and the compound exists as two enantiomers, (1R,19R)-TDHC and 
(1S,19S)-TDHC, in a 1:1 ratio.  The two propionate side chains introduced at the C8- and C12-positions 
are analogous to those of native heme and are included for the purpose of fixing the cofactor in the proper 
position via a hydrogen bonding network with polar amino acid residues in the heme pocket.  The 
CoII(TDHC) complex was added to apomyoglobin obtained by removal of the heme.8  ESI-TOF MS data 
(Figure 1-2) and ICP analysis of the reconstituted protein, rMb(CoII(TDHC)), were used to confirm that 
CoII(TDHC) binds to the protein in a 1:1 ratio.  The UV-vis spectrum of rMb(CoII(TDHC)) has a sharp 
absorption band at 510 nm (Figure 1-3a), which is similar to that observed for the CoII(TDHC) dimethyl 
ester in pyridine.9  Furthermore, the EPR measurement of rMb(CoII(TDHC)) indicates a typical spectrum 
(Figure 1-3b): the interaction of the cobalt nucleus (I = 7/2) with the unpaired electron in a 
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penta-coordinated low-spin d7 configuration of Co(II) results in hyperfine splitting of the signal into an 
octet centered at gz = 1.99, and the presence of a 14N (I = 1) ligand attached to the axial position of the 
CoII(TDHC) complex shows superhyperfine splitting of each component of the octet into a triplet.5,10  
This provides support for the author’s proposal that the cobalt atom coordinates to the Nɛ2-atom of the 
His93 imidazole ring as an axial ligand.11  Furthermore, the binding constant of CoII(TDHC) for 
apomyoglobin was determined by UV-vis spectral changes in the titration experiment to be 20 μM−1 in 0.1 
M potassium phosphate buffer (pH 7.0) at 25 ˚C (Figure 1-4), indicating that CoII(TDHC) is tightly bound 
to form the His-on state. 
 
Scheme 1-1.  Synthetic pathway of CoII(TDHC). 
 
 
 
 
Figure 1-2.  ESI-TOF MS (positive mode) spectrum of rMb(CoII(TDHC)).  Two characteristic peaks are 
consistent with the calculated mass numbers as follows.  m/z (z) for rMb(CoII(TDHC)): 2196.38 (8+), 
2510.18 (7+).  Peaks with the asterisks were assigned as multiply ionized species of apomyoglobin. 
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Figure 1-3.  Characteristic spectra of reconstituted myoglobins: rMb(CoII(TDHC)) (solid line) and 
rMb(CoI(TDHC)) (dashed line).  (a) UV-vis spectra of the reconstituted proteins in 0.1 M potassium 
phosphate buffer (pH 7.0) solution at 25 ˚C.  (b) EPR spectra of the reconstituted proteins (0.5 mM) in 
0.1 M potassium phosphate buffer (pH 7.0) solution at 10 K.  The signal of gx = gy is centered at g = 2.23.  
The coupling constants of |ACoz| and |ANz| for rMb(CoII(TDHC)) are 99.7 and 20.8 G, respectively.  
rMb(CoI(TDHC)) is EPR-silent.   
 
 
 
Figure 1-4.  (a) UV-vis spectral changes of CoII(TDHC) (8.7 μM) at various concentrations of apoMb 
(1.55−15.5 μM) in 0.1 M potassium phosphate buffer solution (pH 7.0) at 25 ˚C.  (b) The plots of 
absorption at 510 nm against concentrations of apoMb with a fitting curve to determine the binding 
constant of CoII(TDHC) for apomyoglobin (K). 
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Figure 1-5.  (a) Crystal structure of rMb(CoII(TDHC)).  The structure of the TDHC framework 
possesses two enantiomers with a ratio of 13:7 due to the configuration of two methyl substituents at C1- 
and C19-positions (Figure 1-1b).  (b) Superimposed structures (top and side views) of the cofactors in 
rMb(CoII(TDHC)) (yellow stick) and native myoglobin (PDB ID: 2V1K) (gray stick). 
 
The crystal structure of rMb(CoII(TDHC)) was obtained at a resolution of 1.30 Å and reveals that 
CoII(TDHC) is bound in the heme pocket with Co(II)–His93 coordination characterized by a Co–Nɛ2 
bond length of 2.18 Å (Figure 1-5).  In the crystals, the ratio of proteins, rMb(CoII((1R,19R)-TDHC)) and 
rMb(CoII((1S,19S)-TDHC)), was found to be 13:7 by the occupancy of the enantiomers because the TDHC 
ligand provides a mixture of two enantiomers due to introduction of two methyl substituents at the C1- and 
C19-positions (vide supra).  Although the TDHC ligand, whose macrocycle is smaller than that of a 
porphyrin, has two methyl substituents oriented perpendicularly to the corrin plane, the position of the 
TDHC framework is remarkably similar to that of the porphyrin framework observed in native myoglobin.  
As a result, the two propionate side chains located at the C8- and C12-positions are found to participate in 
hydrogen bonding networks with Lys45 and Ser92/His97, respectively.  These residues originally interact 
with the heme-propionate side chains in myoglobin.  In addition, the polypeptide Cα atoms of the native 
myoglobin and rMb(CoII(TDHC)) are superimposable with a root-mean-square deviation (RMS value) of 
0.223 Å.12  Although there are several examples of hemoproteins reconstituted with artificial 
porphyrinoid cofactors,8 the present work is the first example of incorporation of a metallocorrin derivative 
into a hemoprotein.   
 
Reduction of the Co(II) species 
Reduction of rMb(CoII(TDHC)) upon addition of dithionite under anaerobic conditions leads to UV-vis 
spectral changes that include clear isosbestic points over 2 s.  The characteristic spectrum of the Co(I) 
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species then appears with an absorption maximum at 530 nm (Figure 1-3a).  The disappearance of the 
characteristic Co(II) low spin EPR signals also indicates the formation of the diamagnetic d8 Co(I) species, 
 
Figure 1-6.  Circular dichroism (CD) spectra of rMb(CoII(TDHC)) (bule solid line) and rMb(CoI(TDHC)) (red 
dashed line), respectively.  Conditions: [protein] = 0.018 mM in 0.1 M potassium phosphate buffer at pH 7.0, at 
25 °C under N2 atmosphere. 
 
 
 
Figure 1-7.  Nernst plots obtained by spectroelectrochemistry of rMb(Co(TDHC)).  The plots obtained from 
the absorption changes at 600 nm of rMb(CoI(TDHC))/rMb(CoII(TDHC)) in spectroelectrochemical 
measurements using an optically transparent thin-layer electrode cell (optical path length of 1 mm) in a glove 
box.  A Pt wire (counter electrode) and a Pt mesh (working electrode) were used along with an Ag|AgCl 
reference electrode.  The potentials of these electrodes were controlled and measured with a Hokuto Denko 
HA-301 potentiostat/galvanostat.  A solution of rMb(CoII(TDHC)) (0.3 mM) was prepared in 0.1 M potassium 
phosphate buffer (pH 7.0) containing 2-hydroxy-1,4-naphthoquinone (0.5 M) as an electron mediator.  At each 
applied potential, the electronic absorption spectra were monitored at 25 °C until no further spectral changes 
were detected. 
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rMb(CoI(TDHC)) (Figure 1-3b).  At pH 7.0, the CD spectrum of rMb(CoI(TDHC)) displays two 
prominent minima at 209 nm and 222 nm, which are typical of a-helical structures, having the consistent 
molar ellipticity values with those determined for rMb(CoII(TDHC)) (Figure 1-6).  The redox potential of 
rMb(CoII(TDHC))/rMb(CoI(TDHC)) was determined by spectroelectrochemical measurements to be –0.13 
V vs. SHE at pH 7.0 (Figure 1-7), while the value of cobalamin in methionine synthase is –0.5 V.13  This 
indicates that rMb(CoI(TDHC)) is more thermodynamically stable than native cob(I)alamin in the protein.   
 
Crystal structure of the Co(I) species 
To understand the coordination behavior of one of the intermediates, cob(I)alamin, during the catalytic 
reaction, the crystals of rMb(CoII(TDHC)) were directly reduced by soaking in a solution of 0.5% (w/v) 
dithionite, and the resulting spectral changes suggest that the Co(I) species is formed in the crystal state.  
The crystal structure of rMb(CoI(TDHC)) was successfully determined at 1.35 Å-resolution (Figure 1-8).  
 
Figure 1-8.  (a) Superimposition of the cofactors and the heme pocket residues of rMb(CoI(TDHC)) (light 
blue) and rMb(CoII(TDHC)) (yellow).  The 2Fo – Fc electron density is shown as a blue grid (contoured at 
1.0 σ) around the His93 residue and the cofactor of rMb(CoI(TDHC)).  (b) and (c) Variations in 
crystallographic B-factors represented as width of the backbone trace in rMb(CoII(TDHC)) (left) and 
rMb(CoI(TDHC)) (right), respectively.  (d) B-factor of the reconstituted proteins.  Summary of B-factor 
values of Cα atoms for rMb(CoII(TDHC)) (blue solid line) and rMb(CoI(TDHC)) (red dashed line).   
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Interestingly, the proximal His93 residue swings out upon cleavage of the Co–N(His93) coordination and 
gains flexibility.  In fact, the decreased electron density of the His93 residue is observed in the 2Fo – Fc 
map (σ = 1.0).  As a result, the distance between the Co(I) and Nɛ2(His93) atoms is 3.44 Å in the crystal 
structure of rMb(CoI(TDHC)).  From the crystal structure it was found that CoI(TDHC) is bound in the 
heme pocket as a tetra-coordinate complex without axial ligands.  This action then induces a steric 
interaction with the 12-propionate side chain, causing it to deviate from its normal position.  Furthermore, 
in rMb(CoI(TDHC)), the backbone B-factors of the F-helix,14 which includes the His93 residue, are found 
to be remarkably large compared to those of rMb(CoII(TDHC)) (Figure 1-8b–d) because of the lack of 
axial ligation.  In contrast, the whole protein structure of rMb(CoI(TDHC)) does not deviate significantly, 
as indicated by the RMS value of all the Ca carbons (0.204 Å).  Additionally, the protein matrix of 
myoglobin is found to be capable of holding the tetra-coordinate cofactor in the heme pocket via hydrogen 
bonding and hydrophobic interactions.  The CD spectrum of rMb(CoI(TDHC)) provides further evidence 
that the α-helicity of the protein is maintained in solution even after release of the axial ligand (vide supra).  
Taken together, these results indicate that the remarkable structural changes occur locally in the proximal 
site upon reduction and do not exert a significant influence on the whole structure of the protein.  To the 
best of the author’s knowledge, this is the first example of a tetra-coordinate structure of a Co(I) species in 
a corrinoid framework.15  It is of particular interest to monitor the unbound form of an axial ligand 
(His-off) in the myoglobin heme pocket in this unique situation.  The author’s data support the 
speculation that the species of methionine synthase referred to as “base-off” cobalamin only requires 
proximal histidine flipping in the process of oxidation/reduction of cobalamin.   
 
1-3.  Summary 
In this chapter, the author has designed and prepared myoglobin reconstituted with the cobalt corrinoid 
complex, Co(TDHC) as a simple model for the active site of a complicated cobalamin-dependent 
methyltransferase.  In the heme pocket of myoglobin, CoII(TDHC) is tightly bound and provides a model 
of the baseoff/His-on state which is seen in the cobalamin binding domain of methionine synthase, and 
then an important intermediate, the tetra-coordinated Co(I) species, is detectable in the protein matrix.   
 
1-4.  Experimental section 
Instruments 
UV-vis spectral measurements were carried out with a Shimadzu UV-3150 or UV-2550 double-beam 
spectrophotometer, or a Shimadzu BioSpec-nano spectrometer.  ESI-TOF MS analyses were performed 
with a Bruker Daltonics micrOTOF mass spectrometer.  1H spectra were collected on a Bruker BioSpin 
DPX400 (400 MHz) spectrometer.  The 1H chemical shift values are reported in ppm relative to a residual 
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solvent peak.  ICP-OES (inductively coupled plasma optical emission spectroscopy) was performed on a 
Shimadzu ICPS-8100 emission spectrometer.  The EPR spectra were measured using a Bruker EMX Plus 
spectrophotometer at the Instrument Center of the Institute for Molecular Science (Okazaki, Japan).  The 
equipment used for X-ray crystallographic analysis is described below.  The pH measurements were 
made with an F-52 Horiba pH meter.  Air-sensitive manipulations were performed in a UNILab glove 
box (MBraun, Germany). 
 
Materials and methods 
All reagents of the highest guaranteed grade available were obtained from commercial sources and were 
used as received unless otherwise indicated.  Distilled water was demineralized using a Barnstead 
NANOpure DIamondTM apparatus.  Dibenzyl 
meso-3,3′-bis(methoxycarbonylethyl)-4,4′-dimethyldipyrromethane-5,5′-dicarboxylate 1 and 
2-formyl-3,4,5-trimethylpyrrole 2 were synthesized according to a previously published method.16,17  A 
standard cobalt solution for ICP-OES was purchased from Wako Pure Chemical Industries. 
 
Preparation of cobalt(II) tetradehydrocorrin (CoII(TDHC)) 
Dipyrromethane derivative 1 (1.4 g, 2.3 mmol) was dissolved in trifluoroacetic acid (TFA) (10 mL) under 
an N2 atmosphere and then HBr/AcOH (25 wt.%, 8 mL) was added to the solution.  After stirring for 8 h 
at room temperature, 2-formyl-3,4,5-trimethylpyrrole 2 (0.67 g, 4.8 mmol) in a methanol solution (20 mL) 
was added dropwise on an ice bath and stirred for 1 h at room temperature.  Diethyl ether (200 mL) was 
added to the reaction mixture and the solution was cooled at –20 ˚C overnight.  The obtained product was 
filtered and washed well with ether to yield a red-brown product of 1,19-dimethylbiladiene-a,c 
dihydrobromide, 8,12-bis(2′-methoxycarbonylethyl)-1,2,3,7,13,17,18,19-octamethylbiladience-a,c 
dihydrobromide 3 (1.4 g, 83%).  1H NMR  (400 MHz, CDCl3): δ 13.31 (br, 2H), 13.25 (br, 2H), 7.11 (s, 
2H), 5.22 (s, 2H), 3.45 (s, 6H), 2.83 (t, J = 8 Hz, 4H), 2.70 (s, 6H), 2.28 (s, 6H), 2.25 (s, 6H), 2.03 (t, J = 8 
Hz, 4H), 2.01 (s, 6H);  HRMS (ESI, positive mode, m/z): [M–HBr2]+ calcd for C35H45N4O4, 585.3435; 
found, 585.3431. 
The 1,19-dimethylbiladiene-a,c compound 3 (0.50 g, 0.67 mmol) and Co(OAc)•4H2O (1.7 g, 6.7 
mmol) were dissolved in methanol (500 ml) and the solution was stirred for 1 h at room temperature.  
After removal of the solvent, methanol (15 mL) and water (3 mL) were added to the residue.  The 
mixture was filtered, and 2 mL of aqueous solution of NaClO4•H2O (0.86 g, 6.1 mmol) was added to the 
filtrate.  After 12 h, the precipitates were collected by filtration and recrystallized from 
methanol/dichloromethane/hexane.  The product of cobalt corrin derivative, 
8,12-bis(2′-methoxycarbonylethyl)-1,2,3,7,13,17,18,19-octamethyltetradehydrocorrin cobalt(II) 
perchlorate 4, was obtained as a dark red solid (0.34 g, 68%).  HRMS (ESI, positive mode, m/z): 
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[M–ClO4]+ calcd for C35H41N4O4Co, 640.2454; found, 640.2460; UV/Vis: ɛmax (CH2Cl2, nm (abs.)) 274.5 
(1.1), 351 (0.92), 489 (0.74), 543.5 (0.37); UV/Vis: ɛmax (pyridine, nm (abs.)) 506 (0.25), 585 (0.085). 
The dimethyl ester of the tetradehydrocorrin cobalt complex 4 (0.10 g, 0.14 mmol), Ca(OH)2 (50 
mg, 0.68 mmol) and LiCl (0.40 g, 9.5 mmol) were dissolved in THF (50 mL) and water (50 mL) and then 
stirred at room temperature for 12 h under an N2 atmosphere.  To the solution, citric acid (1.4 g, 7.3 
mmol) was added and the solution was extracted with CH2Cl2 (200 mL × 2).  The organic phase was 
dried over anhydrous Na2SO4 and the solvent was evaporated under reduced pressure.  The residue was 
dissolved in a minimum amount of CH2Cl2 and reprecipitated with hexane to yield tetradehydrocorrin 
cobalt complex, CoII(TDHC), as a black solid (52.6 mg, 60%).  HRMS (ESI, positive mode, m/z): 
[M–Cl]+ calcd for C33H37N4O4Co, 612.214132; found, 612.214126; UV/Vis: ɛmax (CH3OH, nm (abs.)) 
279.5 (1.2), 495 (0.54), 571 (0.31).  
 
Protein crystallization 
Crystallization of rMb(CoII(TDHC)) was performed at 25 ºC using a hanging-drop vapor-diffusion method.  
The drops were prepared by mixing of 5 μL of 10 mg/mL protein in 0.1 M Tris-HCl (pH 7.4) buffer with 5 
μL of a reservoir solution containing 3.4 M ammonium sulfate and 0.1 M Tris-HCl (pH 7.4).  
Rosette-shaped crystals grew within a week and leaflets were separated for data collection.  The crystal 
was soaked in a cryoprotectant solution (6–12% glycerol in a reservoir solution), fished with a standard 
nylon loop, and flash-cooled in an N2 gas stream at 100 K. 
Crystallization of rMb(CoII(TDHC)) is described bellow.  The rMb(CoII(TDHC)) was also 
crystallized by the method described above with a reservoir solution containing 3.4 M ammonium sulfate, 
0.1 M Tris-HCl (pH 7.4) and 10% trehalose.  The obtained crystal was soaked in the reservoir solution 
with 5 mg/mL sodium dithionite.  A color change from dark red to pink was observed within 1 min and 
the crystal was then fished and flash-cooled in a stream of N2 gas stream. 
 
Crystal structure determination and refinement 
X-ray diffraction data were collected using the synchrotron radiation sources of the beamlines at SPring-8 
(Harima, Japan) or at Photon Factory (Tsukuba, Japan).  Diffraction data were processed with the 
program HKL2000.  The structures were determined by the molecular replacement method using the 
program MOLREP from the CCP4 program suite.  A crystal structure of horse heart myoglobin (Protein 
Data Bank (PDB) ID: 2V1F) was used as the search model.  Refinement was carried out using the 
program REFMAC.  The structures were visualized and modified using the program COOT.  Since 
electron density indicated that two enantiomers of 1R,19R- and 1S,19S-TDHC are present in the heme 
pocket, the author assigned an approximate 1R,19R-TDHC : 1S,19S-TDHC occupancy ratio of 0.65:0.35.  
Data collection and refinement statistics are summarized in Table 1-1.  The final atomic coordinates and 
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structure factor amplitudes were deposited in the Protein Data Bank (PDB).  These have been assigned 
the following ID numbers: 3WFT for rMb(CoII(TDHC)) and 3WFU for rMb(CoI(TDHC)).  Data 
collection and refinement statistics are summarized in Table 1-1. 
 
Table 1-1.  Data collection and refinement statistics for reconstituted horse heart myoglobins 
† Rsym = ΣhklΣi |Ii(hkl)  <I(hkl)>| / ΣhklΣiIi(hkl), where Ii(hkl) is the value of the ith measurement of the 
intensity of a reflection, <I(hkl)> is the mean value of the intensity of that reflection and the summation is 
over all measurements. 
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Detector ADSC Quantum 315r Rayonix MX225HE 
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Chapter 2 
Formation of a Co–C bond and subsequent transmethylation in myoglobin 
reconstituted with the cobalt corrinoid 
 
2-1. Introduction 
Cobalamin-dependent methionine synthase mediates an essential methylation of homocysteine to form 
methionine.1−11  In the catalytic cycle, the enzyme promotes two kinds of methyl group transfers: (i) 
methylation of cob(I)alamin by N5-methyl tetrahydrofolate as a methyl group donor, and (ii) methionine 
synthesis from homocysteine with the methylcobalamin intermediate.  Compared to the non-catalyzed 
reactions, both reactions are ca. 105-fold accelerated by the catalytic activity of the enzyme.12,13  
Elucidation of the mechanisms of these enzymatic reactions is challenging because of the complicated 
enzyme structures and the dynamic conformational changes occurring during activation of the cofactor and 
substrates.2,8,14−24  In this context, cobalt complexes have been investigated as enzyme models with the 
objective of understanding how the organometallic Co–C bond is formed and homolytically cleaved in 
several cobalamin-dependent enzymes.25−38  However, the examples of model reactions of heterolytic 
Co–C bond cleavage, which is seen in methionine synthase, are quite limited30,31 because alkylated 
cobalt(III) complexes including methylcobalamin are generally less reactive with nucleophiles.25−29,32   
Cobalt tetra- and di-dehydrocorrins have been synthesized as representative cobalamin models with 
tetrapyrrole macrocyclic ligands.36−38  It is known that the former has a relatively positive Co(II)/(I)-redox 
potential and the Co(I) species does not have sufficient nucleophilicity to promote attack by alkyl halides 
in organic solvents.36,37  The latter is found to have a relatively negative Co(II)/(I)-redox potential, and 
successive reactions of the obtained R–Co species with a nucleophile have not been reported.38  In 
contrast to these models, it is known that the transmethylation from methylated cobalt phthalocyanine to 
nucleophiles occurs.  This is rationalized by the expectation that Co(I) species would be a good leaving 
group.32−35  However, there are few appropriate enzyme models for investigation of the role of the protein 
matrix, which is expected to stabilize the reaction intermediates and initiate the SN2-like 
transmethylation.1−9,25−38 
The author has developed myoglobin reconstituted with cobalt tetradehydrocorrin Co(TDHC) as a 
His-on methionine synthase model (Figure 2-1), which was prepared and a tetra-coordinated Co(I) species 
was detected in the protein matrix.39  Here, in an effort to replicate the reaction mechanism of methionine 
synthase, the author demonstrates the spontaneous key reactions promoted by the enzyme and by the 
reconstituted protein, rMb(Co(TDHC)): (i) the formation of the methylated Co(III) species from the 
supernucleophilic Co(I) species and (ii) subsequent intraprotein transmethylation in the myoglobin heme 
pocket (Scheme 2-1).39 
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Figure 2-1.  Crystal structure of (a) cobalamin-binding domain of methionine synthase (PDB ID: 1BMT) 
and (b) rMb(CoII(TDHC)) (PDB ID: 3WFT).  (c) Chemical structures of Co(TDHC) dimethyl ester and 
Co(TDHC). 
 
 
Scheme 2-1.  Model reactions of the transmethylations by methionine synthase in the myoglobin matrix 
 
 
 
2-2.  Results and discussion 
The reaction of Co(I) species with methyl iodide in the reconstituted protein 
Addition of methyl iodide to a solution of rMb(CoI(TDHC)) leads to a new absorption maxima at 425 nm 
and 445 nm with disappearance of the 530-nm absorption within 2 h (Figure 2-2a) despite the continued 
absence of EPR signals (Figure 2-2b).  The resulting species is photoactive and gradually converts to the 
Co(II) species upon irradiation with a Xe-lamp under aerobic conditions.  The process is found to be 
accelerated upon the addition of 4-hydroxy-TEMPO (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, free 
radical) as a radical quencher (Figure 2-3).  These findings generally support the fact that the Co(I) 
species reacts with methyl iodide to form the Co–C bond under anaerobic conditions.38,40−42  In this 
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reaction, a nucleophilic pathway is more plausible than a radical pathway which requires an electron 
transfer from the Co(I) species to methyl iodide, because rMb(Co(TDHC)) has the relevantly positive 
Co(I)/Co(II)-redox potential (E = −0.13 V vs. NHE).39,43,44   
 
Figure 2-2.  (a) UV-vis spectra of rMb(CoI(TDHC)) and rMb(CoIII(CH3)(TDHC)) in 0.1 M potassium 
phosphate buffer (pH 7.0) at 25 °C.  (b) EPR spectra of rMb(CoII(TDHC)), rMb(CoI(TDHC)) and 
rMb(CoIII(CH3)(TDHC)) in 0.1 M potassium phosphate buffer (pH 7.0) at 10 K.  
 
 
Figure 2-3.  The spectral changes of rMb(CoIII(CH3)(TDHC)) species induced by photo-irradiation over 
90 sec in the aqueous solution containing 4-hydroxy-TEMPO as a radical quencher.  Solid line and 
dashed line represents the initial and final stages of the photoreaction, respectively.  The aqueous solution 
was irradiated by a 500 W xenon arc lamp filtered with cut-off filters.  The illuminance of the irradiated 
light from 420 nm to 800 nm monitored by a luminometer was 1.8 × 105 lux.  Conditions: [protein] = 
0.024 mM and [4-hydroxy-TEMPO] = 0.038 mM in 0.1 M potassium phosphate buffer (pH 7.0) at 25 °C 
under N2 atmosphere. 
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The CD spectrum of the new species also suggests formation of the Co–C bond in the protein.  In 
the visible region, the positive Cotton effect is observed (Figure 2-4). This effect is also observed in native 
myoglobin and reconstituted myoglobins.45,46  Moreover, the CD spectrum in the far-UV region is 
completely consistent with the spectrum of rMb(CoI(TDHC)) (Figure 2-5).  This rules out dissociation of 
the methylated cofactor from the heme pocket. 
 
 
Figure 2-4.  Circular dichroism (CD) and UV-vis spectra of (a) rMb(CoIII(CH3)(TDHC)) and (b) native 
myoglobin in the visible region.  Solid and dashed lines represent CD and UV-vis spectra, respectively.  
Conditions: (a) [rMb(CoIII(CH3)(TDHC))] = 0.023 mM in 0.1 M potassium phosphate buffer (pH 7.0) at 
25 ºC under N2 atmosphere, (b) [native myoglobin] = 0.0020 mM in the same buffer at 25 °C. 
 
 
Figure 2-5.  CD spectra of rMb(CoI(TDHC)) (dashed line) and rMb(CoIII(CH3)(TDHC)) (solid line).  
Conditions: [protein] = 0.018 mM in 0.1 M potassium phosphate buffer (pH 7.0) at 25 °C under N2 
atmosphere.  In the case of rMb(CoIII(CH3)(TDHC)), the region of the spectrum below 210 nm is omitted 
due to the strong absorption of excess methyl iodide in this region. 
 
The ESI-TOF mass spectrum of the species in the negative ion mode confirms the generation of the 
methylated cobalt corrinoid complex in the protein, rMb(CoIII(CH3)(TDHC)) (Figure 2-6).47  Figure 2-6b 
indicates the characteristic peak at m/z = 2510.10, which is consistent with the mass number of the 7– 
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charge state for rMb(CoIII(CH3)(TDHC)) (calculated m/z = 2510.02).  These findings indicate that the 
nucleophilic Co(I) species reacts with methyl iodide to yield the CoIII(CH3)(TDHC) complex in the heme 
pocket of myoglobin. 
 
 
Figure 2-6.  ESI mass spectrum (negative mode) of rMb(CoIII(CH3)(TDHC)), prepared upon addition of 
methyl iodide to rMb(CoI(TDHC)) at 4 °C in 0.1 M ammonium acetate buffer (pH 6.7).  (a) the raw 
spectrum, and (b) and (c) the expanded spectrum.  The voltage difference between the gas capillary exit 
and the 1st skimmer is 20 V.  The desolvation temperature is 180 ˚C.  The asterisks identify sodium 
adducts of the apoprotein and rMb(CoIII(CH3)(TDHC)). 
 
In contrast to rMb(CoI(TDHC)), no spectral change of CoI(TDHC) dimethyl ester (Figure 2-1c) was 
observed in CH2Cl2 upon the addition of methyl iodide, regardless of the presence of imidazole (1 mM, 40 
eq.) as an axial ligand (Figure 2-7).  The time-course plots of spectral changes at 525 nm clearly indicate 
that the Co(I) complex in the protein39 is more reactive with methyl iodide than the Co(I) complex in 
CH2Cl2.   
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Figure 2-7.  UV-vis spectral changes of the Co(I) species after addition of methyl iodide until 20 min at 
25 °C.  (a) rMb(CoI(TDHC)) in 0.1 M potassium phosphate buffer solution (pH 7); (b) CoI(TDHC) 
dimethyl ester in CH2Cl2; (c) CoI(TDHC) dimethyl ester in CH2Cl2 containing imidazole.  Conditions: 
[Co(I) species] = 25 μM, [CH3I] = 16 mM, [Imidazole] = 1 mM.  (d) Time courses of the spectral changes 
of rMb(CoI(TDHC)) at 525 nm (circle, ○), CoI(TDHC) ester in CH2Cl2 (rhombus, ) and the Co(I) 
complex in CH2Cl2 containing imidazole (triangle, ▵) at 25 °C. Conditions: [Co(I) species] = 25 μM, 
[CH3I] = 16 mM, [imidazole] = 1 mM.   
 
Bond-dissociation energy of methylated complexes 
As discussed above, the protein environment is essential for the formation of the methylated Co(III) 
complex, which indicates that the Co−C bond is stabilized in the heme pocket.  To explain the 
stabilization of methylated Co(III) complexes by axial coordination of imidazole,48 the author computed 
the heterolytic bond-dissociation energy (BDE)49,50 with density functional theory (DFT) calculations 
(Table 2-1 and Figure 2-8).  As listed in Table 2-1, the BDE of the methylated Co(III) complexes can be 
increased by the coordination of imidazole.  The BDEs of the Co–N(Im) bonds for the methylated 
Co(TDHC’) and Co(corrin) complexes49 were computed to be 14.2 and 15.9 kcal/mol, respectively, which 
indicates that the cobalt complexes are significantly stabilized by the coordination of imidazole.51  In 
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contrast, the homolytic BDE of CoIII(CH3)(TDHC’) is higher than that of CoIII(CH3)(Im)(TDHC’) because 
the homolytic cleavage of the Co–C bond does not bring about the Co–N bond dissociation and 
stabilization of the Co(II) species induced by the axial ligation is greater than that of the CH3−Co(III) 
species (Table 2-2).  Thus, it appears that the stability of the methylated Co(III) species is derived from 
His93 ligation in the myoglobin matrix.52 
 
 
Table 2-1.  DFT-computed heterolytic bond-dissociation energy (BDE) and stabilization energy provided 
by imidazole ligation in the gas phase (kcal/mol) 
cobalt 
complex 
BDE of the Co–C bond (kcal/mol) Stabilization by Im-coordinationc (kcal/mol) 
CoIII(CH3)(Im)(Leq)
a CoIII(CH3)( Leq)
b CoIII(CH3)(Im)( Leq) 
Co(TDHC’) 151.0 136.8 14.2 
Co(corrin) 169.6 153.7 15.9 
aThe value of the heterolytic BDE for the imidazole-coordinated Co−CH3 complex consists of the 
dissociation of the Co−CH3 and Co−N(Im) bonds which provides the three fragments: methyl cation, 
imidazole and a corresponding tetra-coordinated Co(I) complex.  bThe value of the heterolytic BDE for 
the Co−CH3 bond.  cThe stabilization energy is evaluated by the BDE value of the Co−N(Im) bond in the 
methylated Co(III) complex with the imidazole ligation. 
 
 
 
Table 2-2.  DFT-computed homolytic bond-dissociation energy (BDE) of the Co–C bond and 
stabilization energy induced by coordination of imidazole in the gas phasea 
cobalt 
complex 
BDE of the Co–C bond (kcal/mol) Stabilization by Im-coordinationd (kcal/mol) 
CoIII(CH3)(Im)(Leq)
b CoIII(CH3)( Leq)
c CoIII(CH3)(Im)( Leq) CoII (Im)( Leq) 
Co(TDHC’) 32.5 41.8 14.3 23.6 
Co(corrin) 36.4 42.3 15.9 21.8 
aLeq is equatorial corrinoid ligand.  
bThe methylated complex is split into two fragments, a methyl radical 
and a corresponding penta-coordinated Co(II) complex with imidazole as an axial ligand.  cThe BDE of 
the Co−CH3 bond of the methylated complex (penta-coordination) was determined.  dThe stabilization 
energy was evaluated by the BDE value of the Co−N(Im) bond in the each imidazole-coordinated complex. 
The energy diagram for the homolytic dissociation is illustrated below. 
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Figure 2-8.  Structure of (a) Co(corrin) and (b) Co(TDHC’) optimized by DFT calculations. 
 
 
Intraprotein transmethylation from the CoIII(CH3)(TDHC) complex 
The author found that the deconvoluted peak intensity of the apoprotein at 16950.5, detected by ESI-TOF 
MS, gradually decreases after addition of methyl iodide to the protein solution of rMb(CoI(TDHC)), and 
then a new peak at 16964.2 appears.  Surprisingly, the in-source decay mode of MALDI-TOF MS shows 
an increase of the sole His64 mass number by +14 over 24 h (Figure 2-9).  The fragment including the 
His64 residue, HGTVVLTALGGILK, was obtained by trypsin digestion and characterized by ESI-TOF 
MS and NMR spectroscopy (see Figure 2-10).  In the 1H and 13C NMR spectra, the characteristic peaks at 
4.05 ppm and 36.31 ppm are respectively assigned to the hydrogen and carbon of the methyl group that 
was transferred to the His64 residue.  These values are completely consistent with those of the authentic 
sample, Nɛ2-methylated histidine as shown in Figure 2-10.53  The NMR study provides a strong 
indication that the methylation reaction selectively occurs at the Nɛ2-position of the His64 imidazole ring.  
In a control experiment, it was found that addition of a large amount of methyl iodide (ca. 640 equiv.) to 
native myoglobin and to myoglobin reconstituted with cobalt protoporphyrin IX leads to non-selectively 
monomethylated protein on the surface in both cases with 50% conversion over 24 h and failure to produce 
the methylated His64 residue.  These results indicate that the Nɛ2 atom of the His64 imidazole 
nucleophilically attacks the activated methyl group bound to the cobalt atom prior to residue- and 
regio-selective transfer of the methyl group within the heme pocket of myoglobin. 
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Figure 2-9.  MALDI-TOF MS (in-source decay mode) spectra of rMb(CoIII(CH3)(TDHC)) treated with 
methyl iodide after the reaction for 0, 3, 6, 14 and 24 h. 
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Figure 2-10.  (a) 13C NMR (150 MHz, D2O/CD3CN (9:1)) spectrum of the H(13CH3)GTVVLTALGGILK 
fragment after trypsin digestion of rMb(CoIII(CH3)(TDHC)).  The fragment was protonated because the 
eluent (H2O/CH3CN) containing 0.1% TFA was used for the HPLC purification.  The chemical shift of 
the 13C-enriched methyl group was determined to be 36.31 ppm.  (b) 13C NMR (100 MHz, D2O/CD3CN 
(9:1) containing 1% TFA) spectrum of Nɛ2-methylated histidine as an authentic sample.53  (The chemical 
shift of the methyl group bounded to the Nɛ2 position was determined to be 36.20 ppm.)  Each 13C signal 
was assigned using the HMQC technique.  (c) 1H NMR (600 MHz, D2O/CD3CN (9:1)) spectrum of the 
peptide of H(13CH3)GTVVLTALGGILK and (d) 1H NMR (400 MHz, D2O/CD3CN (9:1) containing 1% 
TFA) spectrum of Nɛ2-methylated histidine as an authentic sample.   
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Kinetic study of the intraprotein transmethylation 
The first-order rate constant of the transmethylation is determined to be 0.062 h−1 for rMb(Co(TDHC)) by 
conversion of the digested fragments evaluated by HPLC, while the transmethylation does not occur in 
native myoglobin under the same conditions (Figure 2-11).  In contrast, methylcobalamin does not 
provide any spectral changes owing to the transmethylation in 0.1 M phosphate buffer (pH 7.0) in the 
presence of histidine over 12 h.  These findings may be explained by the proximity effect and the low 
heterolytic BDE of CoIII(CH3)(TDHC’)(Im) (151.0 kcal/mol) in contrast to the cobalamin model (169.6 
kcal/mol) (Table 2-1). 
 
 
Figure 2-11.  (a) HPLC traces for the digested peptide fragment (HGTVVLTALGGILK) of 
rMb(Co(TDHC)) after reaction with methyl iodide in 0.1 M potassium phosphate buffer (pH 7.0) at 25 °C 
for 0, 6, 12, 24, 48 h (i−v).  (b) Time courses of the conversion of His64 to methylated His64.  Gray 
circle (●) and black tetragon (■) plots represent the data for rMb(Co(TDHC)) and native myoglobin, 
respectively.  Conditions: [protein] = 25 μM, [sodium dithionite] = 0.6 mM, [CH3I] = 16 mM. 
 
Theoretical calculation of the transmethylation in myoglobin 
To investigate the mechanism of transmethylation in the protein matrix, nucleophilic stepwise and 
concerted pathways were considered in DFT computations as shown in Figure 2-12.23,54  A base-off 
methylated Co(III) complex is produced in the stepwise mechanism.  In the calculations, the author used 
a simplified active site model, in which the two carbon atoms corresponding to the α-carbons of the His64 
and His93 residues and the two -carbons of TDHC pyrroles conjugating each of the propionate side 
chains are fixed at the position of the crystal structure of rMb(CoII(TDHC)) (Figure 2-13a).49,55  As 
shown in Figure 2-13b and Figure 2-14, the axial imidazole is readily displaced from the methylated 
Co(III) complex with an activation barrier of 4.9 kcal/mol to produce a penta-coordinated 
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CoIII(CH3)(TDHC’) intermediate (RCTS1Int).  As discussed above, the Co–C bond is weakened in 
Int, and therefore, the activation barrier of 13.6 kcal/mol in the stepwise pathway is lower than that of the 
concerted pathway (20.2 kcal/mol).  These theoretical results demonstrate that the stepwise pathway via 
the base-off methylated Co(III) complex activated by His93 flipping in rMb(Co(TDHC)) is more plausible 
than the concerted reaction.  The author found that the barriers for the methyl transfer are reduced and the 
final product is significantly stabilized by the dielectric effect of the protein environment.  This is because 
the cobalt complexes are highly polarized in the course of the methyl transfer.  In the crystal structure, the 
Nδ1 atom of the His64 is hydrogen-bonded to a water molecule,39 and therefore, the barriers can be further 
reduced by the partial or full deprotonation of the methylated histidine.23 
 
 
Figure 2-12.  Energy diagrams for the stepwise reaction (red line) and the concerted reaction (blue line) 
for the transmethylation by Co(TDHC’).  Energy values in the gas phase relative to 
CoIII(CH3)(TDHC’)(Im) are indicated. The relative energies in parentheses include the effect of a dielectric 
constant of 4.0. 
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Figure 2-13.  Optimized structures of key species in each transmethylation pathway: reaction complex 
(RC), transition state (TS1, TS2, TSconcerted), intermediate (Int) and product (PRO) in Figure 2-12.  The 
stepwise and concerted pathways consist of RC  TS1  Int  TS2  PRO and RC  TSconcerted  
PRO, respectively. 
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Figure 2-14.  Energy barrier for the deligation of imidazole from the CoIII(CH3)(TDHC’) estimated by 
the DFT calculations.  The maximum point marked with asterisk is identified as a transition state in the 
stepwise pathway.   
 
 
2-3.  Summary 
The author demonstrated the reactivity of the methionine synthase model conjugated between cobalt 
tetradehydrocorrin and apomyoglobin.  The heme pocket of myoglobin is found to enhance the 
nucleophilicity of the Co(I) species and provide a methylated Co(III) species stabilized by the ligation.  
Furthermore, the residue- and regio-selective transmethylation of the Nɛ2 atom of the His64 residue was 
observed at 25 ˚C.  In support of the experimental results, the author’s theoretical calculations indicate 
that His-on/off switching regulates the reactivity of the methylated Co(III) species for both the formation 
and the transmethylation.   
 
2-4.  Experimental 
Instruments 
UV-vis spectral measurements were carried out with a Shimadzu UV-3150 or UV-2550 double-beam 
spectrophotometer, or a Shimadzu BioSpec-nano spectrometer.  ESI-TOF MS and MALDI-TOF MS 
analyses were performed with a Bruker Daltonics micrOTOF mass spectrometer and a Bruker autoflex III 
smartbeam mass spectrometer, respectively.  1H and 13C NMR spectra were collected on a Bruker 
BioSpin DPX400 (400 MHz) or a Varian Unity Inova 600 MHz NMR spectrometer.  The 1H and 13C 
NMR chemical shift values are reported in ppm relative to a residual solvent peak.  ICP-OES (inductively 
coupled plasma optical emission spectroscopy) was performed on a Shimadzu ICPS-7510 emission 
spectrometer. EPR spectra were measured using a Bruker EMX Plus spectrophotometer at the Instrument 
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Center of the Institute for Molecular Science (Okazaki, Japan).  CD spectra were recorded at 25 °C on a 
JASCO spectropolarimeter (Model J-820).  The pH measurements were made with an F-52 Horiba pH 
meter. Air-sensitive manipulations were performed in a UNILab glove box (MBraun, Germany).  A 500 
W xenon arc lamp (Ushio Optical Modulex, SX-U1501XQ) filtered with cut-off filters (Asahi Spectra, 
Super cold filter 5C0751 and HOYA CANDEO OPTONICS, Sharp cut filter L42) was used for 
photo-irradiation experiments.  The illuminance of the irradiated light from 420 nm to 800 nm was 
monitored by a luminometer (MINOLTA, Illuminance meter T-10P). 
 
Materials and methods 
All reagents of the highest guaranteed grade available were obtained from commercial sources and were 
used as received unless otherwise indicated.  Distilled water was demineralized using a Barnstead 
NANOpure DIamondTM or Millipore Integral3 apparatus. Syntheses of tetradehydrocorrin dimethyl ester 
cobalt complex, Co(TDHC) dimethyl ester, and tetradehydrocorrin cobalt complex, Co(TDHC) were 
reported in the author’s previous work.39  Native horse heart myoglobin (Sigma Aldrich) was purified 
with a cation exchange CM-52 cellulose column.  The apoprotein was prepared according to Teale’s 
method.56,57  The reconstituted protein, rMb(CoII(TDHC)), was obtained by the conventional method.39  
A cobalt standard solution for ICP-OES was purchased from Wako Pure Chemical Industries. 
 
Reduction of rMb(CoII(TDHC)) and following methylation 
The following procedures were performed in a glove box (O2 < 0.1 ppm).  A solution of sodium 
dithionite (10 mg/mL, 10 μL, 0.57 μmol) in 0.1 M potassium phosphate buffer (pH 7.0) was added to 1 mL 
of rMb(CoII(TDHC)) solution (25 μM) in the same buffer at 25°C.  A solution of rMb(CoI(TDHC)) was 
immediately obtained.39  To the solution, methyl iodide (1 μL, 16 μmol) was added to yield an 
organometallic species, rMb(CoIII(CH3)(TDHC)), within 2 h.  The reaction was monitored by performing 
UV-vis spectral measurements at 25 °C. 
 
EPR measurements 
The measurements of EPR spectra were carried out at the X-band (9.35 GHz) microwave frequency with 
100 kHz field modulation and 10 G of modulation amplitude.  During EPR measurements, the sample 
temperature was maintained at 10 K by an Oxford Instruments ESR900 cryostat equipped with a turbo 
pump to lower the vapor pressure of the liquid He.  Each protein solution (0.5 mM) in 0.1 M potassium 
phosphate buffer (pH 7.0) was placed in a 5 mm tube.  The sample was quickly frozen in a cold pentane 
bath chilled with liquid N2. 
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Preparation of rMb(CoIII(CH3)(TDHC)) for the ESI mass spectrometry experiment. 
The sample solution was prepared in degassed water prior to use in a nitrogen-purged glove box (O2 < 0.1 
ppm).  To a solution of rMb(CoII(TDHC)) (0.1 mM, 0.5 mL, 50 nmol) in 0.1 M ammonium acetate buffer 
(pH 6.7), sodium dithionite (57 mM, 1.6 mL, 91 nmol) and saturated CH3I (99 mM, 25 μL, 2.5 μmol) in 
the same buffer were added and the solution was allowed to stand for 1 h at 4 °C. 
 
Identification of a methylated amino acid residue in the protein 
Site-specific methylation in the protein was confirmed by the in-source decay mode on a Bruker autoflex 
III smartbeam mass spectrometer (MALDI-TOF MS).  As a matrix solution, 1,5-diaminonaphthalene was 
saturated in a mixture of CH3CN and 0.1% TFA aqueous solution (1/1 v/v).  After the methyl transfer 
reaction, the protein solution was purified by HiTrap Desalting (5 mL, GE Healthcare).  To 1 µL of the 
concentrated protein solution (0.1 mM) was added 5.0 μL of the matrix solution, and then 1 µL of the 
mixed solution was placed on a sample plate.  The solvent was evaporated under ambient conditions.  
All mass spectra were acquired in positive ion mode. 
For the NMR study, the methylated protein was prepared by 13C-enriched methyl iodide.  The 
concentrated protein solution (0.25 mM, 1 mL) was passed through a HiTrap Desalting column (GE 
Healthcare) equilibrated with 50 mM Tris-HCl buffer (pH 8.0) containing 6 M guanidine HCl.  After 
denaturation of the protein by incubation of the collected solution at 95 °C for 20 min, the buffer was 
exchanged to 50 mM Tris-HCl buffer (pH 7.6) containing 1 mM CaCl2 using the same gel filtration 
column.  To the solution, Sequencing Grade Modified Trypsin (Promega) (0.5 mg/mL, 20 μL) was added 
and the mixture was incubated at 37 °C for 24 h.  The peptide fragment containing methylated His64, 
H(13CH3)GTVVLTALGGILK, was isolated by HPLC with a YMC-Pack Pro C18 column 
(water/acetonitrile co-solvent containing 0.1% TFA).  Purification was performed at a flow rate of 8 
mL/min with a linear gradient of two eluents for 60 min.  The isolated peptide was characterized by 
ESI-TOF MS: found m/z = 1392.854, calculated m/z = 1392.857 (z = 1+).  1H and 13C NMR spectra of the 
isolated peptide fragment in 10% acetonitrile-d3 in D2O solution were obtained on 600 MHz NMR 
instrument at 25 °C. 
 
HPLC analysis for the kinetics of the transmethylation 
The transmethylations reactions of native myoglobin and rMb(Co(TDHC)) were evaluated by HPLC 
analysis. 
Native myoglobin: The solution of native myoglobin (25 μM, 3 mL) in 0.1 M potassium phosphate 
buffer solution (pH 7.0) was reduced with 30 μL of 10 mg/mL sodium dithionite (54.8 mM) in the same 
buffer solution and then methyl iodide (3 μL) was added.  At desired reaction times (0, 3, 7, 12, 24, 48 h), 
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the protein solution (25 μM, 0.5 mL) was passed through a PD MiniTrap G-25 column (GE Healthcare) 
equilibrated with 50 mM Tris-HCl buffer (pH 8) containing 6 M guanidine HCl at 4 ºC.  The buffer was 
exchanged to 50 mM Tris-HCl buffer (pH 7.6) containing 1 mM CaCl2 using the same gel filtration 
column and the solution was concentrated to 50 μL using an Amicon Ultra-4 Centrifugal Filter (10 kDa) 
(GE Healthcare).  To the solution, Sequencing Grade Modified Trypsin (Promega) (0.05 mg/mL, 1 μL) 
was added and the mixture was incubated at 37 ºC overnight. 
rMb(CoII(TDHC)): The protein (25 μM, 5 mL) in 0.1 M potassium phosphate buffer solution (pH 
7.0) was reduced with 50 μL of 10 mg/mL sodium dithionite (54.8 mM) in the same buffer solution and 
then methyl iodide (5 μL) was added. At desired reaction times (0, 6, 12, 24, 48 h), each protein solution 
(12.5 μM, 1 mL) was dissolved in 4 mL of 17 mM Tris-HCl buffer (pH 8) containing 1 M guanidine HCl 
at 4 ºC.  After concentration to 0.5 mL, the protein solution was passed through the same gel filtration 
column equilibrated with 17 mM Tris-HCl buffer (pH 7.5) containing 1 M guanidine HCl at 4 ºC.  The 
buffer was exchanged to 50 mM Tris-HCl buffer (pH 7.6) containing 1 mM CaCl2 and concentrated until 
50 μL using the same centrifugal filter.  To each solution, Sequencing Grade Modified Trypsin (Promega) 
(0.5 mg/mL, 1 μL) was added and the mixture was incubated at 37 ºC for 2 h. 
The solutions containing the peptide fragments were analyzed by HPLC with a YMC-Pack Pro C18 
column.  The analysis was performed at a flow rate of 1 mL/min of 75% or 78% water/acetonitrile 
co-solvent containing 0.1% TFA for 40 or 70 min in a column oven at 60 ˚C, respectively.  Each fraction 
was characterized by ESI-TOF-MS. 
The fractions of the peaks located at about 56 and 58 min were assigned to the peptide containing 
non-methylated His64, HGTVVLTALGGILK, and the peptide containing methylated His64, 
H(CH3)GTVVLTALGGILK, by ESI-TOF MS.  Found m/z = 1378.813 (56 min) and 1392.829 (58 min), 
calculated m/z = 1378.841 (z = 1+) and 1392.857 (z = 1+).  The concentration of the methylated peptide 
was determined from the ratio of peak areas of methylated and non-methylated peptides.   
 
Computational chemistry 
The author used the Becke–Perdew (BP86)58,59 method implemented in the Gaussian 09 program.  For all 
atoms, the 6-31G(d) basis set was used.  This level of theory BP86/6-31G(d) serves as an appropriate 
platform for addressing the structural, electronic, and spectroscopic properties of cobalamin cofactors.60–66  
All calculations were carried out in the gas phase unless otherwise noted.  To explore the realistic 
reaction pathways, the author used a truncated model of Co(TDHC) where all peripheral side chains of 
TDHC were replaced with hydrogens.  The positions of four atoms marked with asterisk * in Figure 2-13 
are constrained at the coordinate of the crystal structure (PDB ID: 3WFT) to retain the structure of the 
active site.  All of the transition states were characterized by an imaginary frequency mode that 
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corresponds to the motion along the reaction coordinate under consideration.  The dielectric effect of 
protein environment on the transmethylation reaction was estimated at the BP86/SV(P) level of theory by 
using the conductor-like screening model67 (COSMO) implemented in the TURBOMOLE program.  The 
dielectric constant was chosen to be 4, which is a standard value that has been used in previous studies.23 
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Chapter 3 
Coordination behavior of aqua- and cyano-Co(III) corrinoids with histidine-ligation 
in the myoglobin matrix 
 
3-1.  Introduction 
Methionine is responsible for catalysis of a transmethylation reaction and it is noted that the reaction via 
the heterolytic cleavage of the Co–CH3 bond of methylcobalamin is accelerated by ca. 105-fold within the 
enzyme compared to the non-enzymatic reaction.1,2b,d,3  To understand the enzymatic reaction mechanism, 
it is essential to consider the effects on the electronic and structural properties of the corrin framework as 
well as the axial ligand.4–11  To evaluate the chemical properties of the corrin framework, two 
characteristic cobalt corrinoids, di- and tetradehydrocorrin cobalt complexes, have been reported as models 
of cobalamin.4  Furthermore, several substituted cobalamins with substitution at the 10-position of the 
corrinoid and cobalt corrole derivatives have been also synthesized to investigate the framework-effect 
using theoretical and experimental methods.5,6  In addition to the framework-effect, various cobalamin 
derivatives were synthesized to investigate the axial-ligation effect, particularly the relationship between 
the Co–C and Co–N(DMB) bond lengths.1d,5b,7  A bulky axial ligand such as DMB is known to cause 
elongation of the Co–C bond due to upward folding of the corrin ring.1d,8  This axial ligation generally 
promotes homolytic cleavage of the Co–C bond as a result of electronic stabilization of the produced 
Co(II) species.1d,8  In contrast, there are few appropriate cobalamin models which replicate the 
DMB-off/His-on ligation which occurs in the reaction cycle of methionine synthase, where the methyl 
group bound to the cobalt atom is transferred to homocysteine via the heterolytic Co–C bond cleavage.9,12  
To evaluate the effect of the histidine ligation, it is of interest to construct a conjugate model between a 
cobalt complex and a protein matrix.10,11,13 
Myoglobin reconstituted with tetradehydrocorrin cobalt complex, rMb(Co(TDHC)), was prepared to 
replicate the cobalamin-binding domain of methionine synthase.10  Furthermore, it has been found that 
the Co(I) species reacts with methyl iodide to form the Co–CH3 bond and the subsequent intraprotein 
transmethylation occurs in the heme pocket.4,11  In these transmethylation events as a model reaction of 
methyltransferase, the theoretical study suggests that ligation and de-ligation of the axial histidine residue 
in the myoglobin matrix has important roles for the formation and activation of the CH3–Co(III) species, 
respectively.  However, an X-ray crystal structure of the methylated complex has not been available 
because the organometallic Co(III) species is more unstable than methylcobalamin11 and rapidly 
decomposes when subjected to X-ray irradiation.14  Here, the author reports the structures and 
physicochemical properties of relatively stable aqua- and cyano-Co(III) complexes of myoglobin, 
rMb(CoIII(OH2)(TDHC)) and rMb(CoIII(CN)(TDHC), respectively, as models of methylcobalamin in the 
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enzyme matrix (Scheme 3-1). 
 
Scheme 3-1.  Reaction scheme for oxidation of rMb(CoII(TDHC)) and subsequent ligand exchange with 
a cyanide ion. 
 
 
 
3-2.  Results and discussion 
Preparation of rMb(CoIII(OH2)(TDHC) by oxidation of rMb(CoII(TDHC)) 
Addition of K3[Fe(CN)6] to a solution of rMb(CoII(TDHC)) in 0.1 M phosphate buffer at pH 7.0 leads to a 
new set of absorption maxima (λmax) at 657 nm and 687 nm with disappearance of the 510-nm absorption 
(Figure 3-1a).  These new absorption bands have been attributed to an intermolecular charge transfer 
transition for the cobalt–axial ligand bond of the CoIII(TDHC) species.4d  As a reference experiment, the 
author also monitored the UV-vis spectral change of the bare CoIII(TDHC) complex in the same buffer 
containing K3[Fe(CN)6] upon addition of imidazole (Im) as an axial ligand.  The obtained spectrum of the 
Im-ligated CoIII(TDHC) species is generally consistent with that of CoIII(TDHC) in the protein (Table 3-1), 
indicating that CoII(TDHC) is oxidized by K3[Fe(CN)6] to form the Co(III) species, 
rMb(CoIII(OH2)(TDHC)), coordinated by the His93 residue in the heme pocket of myoglobin at pH 7.0. 
 
 
Figure 3-1.  (a) UV-vis spectra of rMb(CoII(TDHC)) (dashed line) and rMb(CoIII(OH2)(TDHC)) (solid 
line) in 0.1 M potassium phosphate buffer at pH 7.0 at 25 ˚C.  (b) UV-vis spectral changes of 
rMb(CoIII(OH2)(TDHC)) upon addition of cyanide in the same buffer. 
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Table 3-1.  UV-vis spectral absorption data in 0.1 M potassium phosphate buffer at pH 7.0 at 25 ºC 
protein or complex λmax (nm) [ɛa ( mM–1 cm–1)] 
rMb(CoIII(OH2)(TDHC)) 629 [10.0], 686 [19.6] 
rMb(CoIII(CN)(TDHC)) 652 [10.2], 716 [16.7] 
rMb(CoII(TDHC))b 510 [16.4] 
CoIII(TDHC)L2
 c 629 [11.0] 
CoIII(TDHC)L2 + Im
d 629 [9.1], 677 [11.7] 
CoIII(CN)2(TDHC) 671 [8.0], 740 [11.6] 
aThe molar coefficient was determined from ICP-OES measurements. bRef. 10. cL = H2O or OH–. 
dCoIII(TDHC) (5.2 μM) in 0.1 M phosphate buffer containing 1 mM of Im. 
 
Increasing the pH value of the oxidized protein solution induces spectral changes with isosbestic 
points (Figure 3-2a), which are derived from deprotonation of a water molecule coordinated to the cobalt 
atom in the reconstituted myoglobin (eq 1). 
 
rMb(CoIII(OH2)(TDHC))  rMb(CoIII(OH)(TDHC) + H+    (1) 
 
A pKa value of 7.5 for the coordinated water molecule in rMb(Co(OH2)(TDHC)) was determined from 
data obtained in a pH titration experiment (Figure 3-2b).  This pKa value is similar to that of base-on 
aquacobalamin (pKa = 7.8) and higher than that of base-off diaquacobalamin (pKa = 6.0), where the 
base-on and base-off transitions represent the transitions of the intramolecular DMB-ligated and 
H2O-ligated forms in the cobalamin molecule, respectively.15  This finding suggests that the His93 
residue coordinates to CoIII(TDHC) in myoglobin (His-on) under conditions of neutral pH.   
 
 
Figure 3-2.  (a) UV-vis spectral changes occurring with increasing pH (pH 7–9) at 25 ºC.  (b) The pH 
titration curve of the absorbance at 686 nm, which is the absorption maximum of rMb(CoIII(OH2)(TDHC)). 
 47 
Ligand exchange to obtain the cyano-Co(III) complex 
The coordinated water molecule in rMb(CoIII(OH2)(TDHC)) is exchangeable with a cyanide ion upon 
addition of a solution of KCN, giving red shifted absorption maxima at 652 nm and 716 nm (Figure 3-1b 
and Table 3-1).  These maxima are different from those of the bare CoIII(CN)2(TDHC) complex, which 
are consistent with those of the reported Co(III) tetradehydrocorrin dicyano-complex in CH2Cl2.4d  These 
results support the formation of a monocyano-adduct of CoIII(TDHC) with the His93 coordination in the 
heme pocket of myoglobin, rMb(CoIII(CN)(TDHC)), as characterized by ESI-TOF MS.  The affinity of 
the cyanide for rMb(CoIII(OH2)(TDHC)) was determined by relaxation analysis16 and indicated a K value 
of 8.9 × 105 M–1 at pH 7.0, which is lower than that of CNCbl (≥ 1012 M–1).15 
Interestingly, rMb(CoIII(CN)(TDHC)) can also be obtained by autoxidation of the Co(II) species in 
the reconstituted protein upon addition of an excess amount of cyanide (10 eq) under aerobic conditions, 
whereas similar oxidation does not occur in the absence of cyanide.  The oxidation appears to be initiated 
by coordination of cyanide to the Co(II) species, which would lead to a negative shift of the 
Co(II)/Co(III)-redox potential of Co(TDHC). 
 
Crystal structures of rMb(CoIII(OH)(TDHC)) and rMb(CoIII(CN)(TDHC)) 
The crystal of myoglobin with the Co(III) species was obtained by soaking the crystal of 
rMb(CoII(TDHC))10 in a reservoir solution containing K3[Fe(CN)6] (15.2 mM) at pH 7.4. At this pH, 
approximately half of the coordinated water molecules in rMb(CoIII(OH2)(TDHC)) are deprotonated to 
rMb(CoIII(OH)(TDHC)) at room temperature (vide supra).  In addition, the pH value of the reservoir 
solution containing 0.1 M Tris-HCl buffer is found to increase at low temperature, suggesting that the 
water molecule coordinated to CoIII(TDHC) will be deprotonated to form rMb(CoIII(OH)(TDHC)) under 
the conditions used for data collection at 100 K.   
The color of the rMb(CoIII(OH)(TDHC)) crystal changes from green to deep red after X-ray 
irradiation, indicating that the Co(III) species is reduced to the Co(II) species by the generated 
photo-electron and/or hydroxyl radical in the protein.14  The X-ray crystal structure of the reconstituted 
protein was determined and refined at 1.20 Å resolution (Figure 3-3a).  The cofactor is bound in the heme 
pocket by Co–N(His93) ligation. 
The electron density map clearly shows two oxygen atoms above the cobalt atom of Co(TDHC).  
Each oxygen occupancy is assigned to be 50% and the distances of Co–O1 and Co–O2 are 1.86 Å and 3.01 
Å, respectively (Figure 3-4a).  These results suggest that under X-ray irradiation, the hexa-coordinated 
CoIII(OH)(TDHC)–His93 complex is partially reduced to form the penta-coordinated CoII(TDHC)–His93 
complex in the heme pocket.  After cleavage of the Co–OH bond of rMb(CoIII(OH)(TDHC)), it appears 
that the released hydroxide accepts the proton bound to the Nɛ2 atom of the His64 residue (Figure 3-4b).  
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The produced water molecule is located in the heme pocket and participates in hydrogen bonding with the 
Nɛ2 atom of the His64 residue with an O2–Nɛ2 distance of 2.60 Å.  Furthermore, the crystal structure 
reveals that the Co–O bond length of rMb(CoIII(OH)(TDHC)) is shorter than the Fe–O bond length of 
native met-aquo myoglobin and the Co–O bond length of myoglobin reconstituted with cobalt 
protoporphyrin IX, rMb(CoIII(OH2)(PP)).  Furthermore, the Co–O bond length of 
rMb(CoIII(OH)(TDHC)) is much shorter than that of aquacobalamin, H2OCbl,17a and is also shorter than 
that of hydroxocobalamin, OHCbl, (Table 3-2).7c  The relatively short Co–O bond length indicates that 
the water molecule coordinated to the cobalt atom is deprotonated to form the hydroxide ion observed in 
the crystal structure (Table 3-2).   
 
 
Figure 3-3.  Crystal structures of (a) rMb(CoIII(OH)(TDHC)) and (b) rMb(CoIII(CN)(TDHC)).  The 
whole protein structure (each left), and the structure of cofactor with axial ligand (each right) are shown.  
Each cofactor consists of two enantiomers, (1R,19 R)-TDHC and (1S,19S)-TDHC, with a ratio of 65:35 
due to two chiral centers at the C1- and C19-positions of the corrinoid framework.   
 
 
 
Figure 3-4.  (a) Electron density map of the cofactor of rMb(CoIII(OH)(TDHC)).  The 2Fo – Fc electron 
density is shown as a blue mesh for the cofactor and a red mesh for the oxygen atoms above the cobalt 
atom (contoured at 1.0 σ).  (b) Plausible scheme for the reduction of rMb(CoIII(OH)(TDHC)) to 
rMb(CoII(TDHC)) upon X-ray irradiation.   
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Table 3-2. Bond lengths of axial coordination for Co(TDHC)s or cobalamins 
protein or complex M–Xa (Å) M–N(axial ligand) (Å) b 
rMb(CoIII(OH)(TDHC))c 1.86 2.09 
rMb(CoIII(CN)(TDHC))c 2.09 2.13 
rMb(CoII(TDHC))d – 2.17 
nMb(FeIII(OH2)(PP))
e 2.29 2.26 
rMb(CoIII(OH2)(PP))
f 2.46 2.15 
H2OCbl
g 1.95 1.93 
OHCblh 1.92 1.99 
CNCbli 1.89 2.04 
CNCbl–Imj 1.86 1.97 
Cob(II)alamink – 2.13 
aX is the 6th ligand: X = OH–, CN– or H2O.  
bDistance between the Co–N(His93) and Co–N(DMB) bonds 
for myoglobin and cobalamin, respectively.  cThis work. dRef. 10. PDB ID: 3WFT.  eRef. 17b. PDB ID: 
1YMb.  fRef. 17c. PDB ID: 2O5T.  gAquacobalamin.  Ref. 17a. hHydroxocobalamin.  Ref. 7c. 
iCyanocobalamin (CNCbl).  Ref. 7a. jDMB of CNCbl was substituted with Im.  Ref. 7e. 
kPenta-coordinated Co(II)species of cobalamin.  Ref. 7d.   
 
The author also determined the X-ray crystal structure of rMb(CoIII(CN)(TDHC)) at 1.40 Å 
resolution (Figure 3-3b).  In this case, the X-ray irradiation-induced reduction was not observed.  The 
crystal structure shows the hexa-coordinated CoIII(CN)(TDHC) complex bound in the heme pocket by 
Co–N(His93) ligation.  To the best of the author’s knowledge, this is the first known instance of 
determination of 3D-structures of a hexa-coordinated Co(III) tetradehydrocorrin complex with two 
different ligands at the axial positions.4d 
Table 3-2 provides a comparison of several bond distances between axial ligands and metal 
cofactors.  The Co–N(His93) bonds of the reconstituted myoglobins are longer than the Co–N(DMB) 
bonds of the corresponding cobalamins, although the substitution of DMB of cyanocobalamin (CNCbl) 
with Im is known to provide a shorter Co–N bond.7e,18  The oxidation of rMb(CoII(TDHC)) provides a 
shorter Co–N(His93) bond in rMb(CoIII(OH)(TDHC)), which is consistent with the fact that the bond 
length of OHCbl is shorter than that of Cob(II)alamin.  Furthermore, the replacement of hydroxide in 
rMb(CoIII(OH)(TDHC)) with cyanide elongates the Co–N(His93) bond in rMb(CoIII(CN)(TDHC)).  This 
also occurs during the conversion from OHCbl to CNCbl.  Next, comparing the structures of the three 
cyano-Co(III) complexes listed in Table 3-2, the author found that the Co–N(axial ligand) bond elongates 
with increasing length of the Co–CN bonds in the order of CNCbl-Im < CNCbl < rMb(CoIII(CN)(TDHC)).  
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These cyano-Co(III) complexes exhibit an inverse trans effect-like property on both axial bond lengths.7   
Moreover, the polypeptide Cα atoms of rMb(CoIII(OH)(TDHC)) and rMb(CoIII(CN)(TDHC)) are 
superimposable on those of nMb with root-mean-square (RMS) deviation values of 0.225 Å and 0.264 Å, 
respectively.  The oxidation of rMb(CoII(TDHC)) and the subsequent ligand exchange from hydroxide to 
cyanide do not have a significant influence on structural changes of the protein matrix, although the 
reduction of the Co(II) species provides a His-off state via flipping of the His93 residue with a 
significantly high B-factor.10  However, the ligation of cyanide provides slightly higher B-factor values of 
the His93 residue of rMb(CoIII(CN)(TDHC)) than those of rMb(CoIII(OH)(TDHC)) and rMb(CoII(TDHC)) 
(Figure 3-5).  This suggests that the Co–N(His93) bond slightly weakens upon binding of cyanide. 
 
 
Figure 3-5.  Variations in crystallographic B-factors of the axial ligands of the reconstituted proteins are 
represented as both the value and sphere size of each atom: (a) rMb(CoIII(OH)(TDHC)), (b) 
rMb(CoIII(CN)(TDHC)), (c) rMb(CoII(TDHC))11 and (d) rMb(CoI(TDHC))11. 
 
 
NMR spectroscopy 
The 13C NMR spectra of rMb(CoIII(CN)(TDHC)) are shown in Figure 3-6, in which Figure 3-6a was 
obtained from a sample with 13C-enriched KCN.  The differential spectrum (Figure 3-6a – Figure 3-6b) 
gives two peaks at 108.4 ppm and 110.6 ppm assigned as 13C-enriched cyanide bound to the cobalt ion in 
the protein matrix (Figure 3-6c), because of the mixture of the two cofactor enantiomers in the asymmetric 
protein matrix (vide supra).  A ratio of the areas of these peaks was determined to be 6:4 (Figure 3-6d), 
which is similar to the ratio estimated by crystallography.   
Chemical shifts of the cyanide peak in cyano-cobalt corrinoids are listed in Table 3-3.  In 
comparison with dicyanocobalamin, (CN)2Cbl, CNCbl(base-on) and Co(CN)2(TDHC), the 13C-cyanide 
peak of rMb(CoIII(CN)(TDHC)) undergoes an up-field shift.  The similar up-field shift of the cyanide 
peak is seen in CNCbl(base-off).  Taken together, these findings suggest that the weaker σ-donation from 
the cyanide ion to the cobalt ion relative to CNCbl(base-on) is due to the longer Co–CN bond of 
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rMb(CoIII(CN)(TDHC)) than that of CNCbl. 
 
 
Figure 3-6.  13C NMR (150 MHz) spectra of rMb(CoIII(CN)(TDHC)) prepared with (a) 13C-enriched and 
(b) non-enriched KCN in 0.1 M potassium phosphate buffer at pH 7.0 containing 10% D2O.  The 
asterisks identify the peaks of glycerin at 63.17 ppm and 71.90 ppm as a reference.  (c) The differential 
spectrum of a – b.  (d) Expanded NMR spectrum of rMb(CoIII(13CN)(TDHC)) (dash line) with simulated 
spectra of the peaks at 108.4 ppm, 110.6 ppm and 112.3 ppm (gray dashed line), and the sum of the 
simulated spectra (in green solid line) for the determination of the ratio of the areas. 
 
 
Table 3-3.  13C-NMR chemical shifts of cyano-cobalt corrinoids 
protein or complex δ (ppm) 
rMb(CoIII(CN)(TDHC))a 
108.4 
110.6 
CNCbl(base-on)b 121.4 
CNCbl(base-off)b 111.8 
Co(CN)2(TDHC)
a 112.7 
(CN)2Cbl
b,c 140.2 
aThis work.  bRef. 19.  cDicyanocobalamin. 
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IR spectroscopy 
IR spectra of rMb(CoIII(13CN)(TDHC)) and rMb(CoIII(12CN)(TDHC)) are shown in Figure 3-7. The 
13CN/12CN-differential spectrum clearly shows the typical isotope shift.20  The stretching frequency of the 
cyanide ion in rMb(CoIII(12CN)(TDHC)) which is assigned at 2151 cm–1 is higher than that of both the 
mono- and di-cyanocobalamins and Co(CN)2(TDHC) (Table 3-4).  The higher stretching frequency of the 
cyanide ion in rMb(CoIII(CN)(TDHC)) is due to weak π-back donation from the cobalt atom to the cyanide 
ion,21 indicating that the Co–CN bond is weakened relative to that of CNCbl.  These findings are 
supported by the observation that the Co–CN bond in rMb(CoIII(CN)(TDHC)) is longer than that of CNCbl, 
as revealed by X-ray crystallography (vide supra).   
 
Figure 3-7.  IR spectra of rMb(CoIII(CN)(TDHC)) prepared with K13CN and K12CN.  Conditions: 
[protein] = 6 mM in 0.1 M potassium phosphate buffer at pH 7.0 at 25 ˚C. 
 
 
Table 3-4. Cyanide stretching frequencies in cyanocorrinoids 
protein or complex wavenumber (cm–1) 
rMb(CoIII(CN)(TDHC))a 2151 
Co(CN)2(TDHC)
b 2128 
CNCblc 2137 
(CN)2Cbl
c,d 2119 
aThis work.  bRef. 21a.  cRef. 21b.  dDicyanocobalamin. 
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Determination of pK1/2 values for reconstituted myoglobins 
The pK1/2 value for each reconstituted protein, which represents the pH value corresponding to a 50% loss 
of a cofactor from the myoglobin matrix via the cleavage of the metal–N(His93) bond, was determined by 
fitting the titration curve (Figure 3-8 and Table 3-5).  From the UV-vis spectral changes of 
rMb(CoIII(OH2)(TDHC)) and rMb(CoII(TDHC)) which occur when the pH decreases, the pK1/2 values 
were determined to be 3.2 and 5.5, respectively.  rMb(CoIII(OH2)(TDHC)) has the lower pK1/2 value than 
rMb(CoII(TDHC)), indicating that the oxidation of the Co(II) species enhances the Co–N(His93) bond 
strength because the Co(III) species has higher Lewis acidity than the Co(II) and Fe(III) species.  In 
contrast, the pK1/2 value of rMb(CoIII(CN)(TDHC)) is 2.3 pH units higher than that of 
rMb(CoIII(OH2)(TDHC)) (Figure 3-8c), while the pK1/2 values of nMb(FeIII(OH2)(PP)) and 
nMb(FeIII(CN)(PP)) are slightly different (0.3 pH units).  Table 3-5 also demonstrates that in the case of 
cobalamins, an increase in the electron-donating ability of an axial ligand increases the pKbase-off values 
(see the legend under Table 3-5),7f,15 indicating that the strong electron donating cyanide ligand weakens 
the Co–N(His93) bond of rMb(CoIII(CN)(TDHC)).  This finding is supported by the IR and X-ray 
structure data which indicate elongation of the Co–N(His93) bond.   
 
Figure 3-8.  UV-vis spectral changes of (a) rMb(CoIII(OH2)(TDHC)) and (b) rMb(CoIII(CN)(TDHC)) 
occurring with decreasing pH at 25 ºC.  (c) The pH titration curves of the absorbance at 686 nm for 
rMb(CoIII(OH2)(TDHC)) (triangle, ▲) and at 716 nm for rMb(CoIII(CN)(TDHC)) (circle, ●). 
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Table 3-5.  The pK1/2 values for reconstituted and native myoglobins and the pKbase-off values for 
cobalamins 
protein or complex pK1/2 or pKbase-off  
rMb(CoIII(OH2)(TDHC))
a 3.2 
rMb(CoIII(CN)(TDHC))a 5.5 
rMb(CoII(TDHC))a 5.0 
nMb(FeIII(OH2)(PP))
a 5.0 
nMb(FeIII(CN)(PP))b 5.3 
H2OCbl
c,d –2.4 
CNCblc 0.1 
methylcobalaminc 2.5 
aThis work. bRef. 22. cRef. 16. dAquacobalamin. 
 X is the 6th ligand: X = OH–, CN– or CH3–. 
 
 
Theoretical calculations for the Co(III) species of the TDHC and corrin frameworks 
To characterize the weakening of the Co–N(His93) bond of the Co(III) species by axial coordination of 
cyanide, the author computed the BDE with density functional theory (DFT) calculations (Table 3-6).  As 
truncated models of Co(TDHC) and cobalamin, the author used Co(TDHC’) and Co(corrin), where all of 
the peripheral side chains are replaced with hydrogen atoms for the DFT calculations (Figure 3-9).  Im 
was used as a simplified model of the axial His93 residue.  The BDEs of the Co–N(Im) bonds of 
CoIII(OH2)(Im)(TDHC’) and CoIII(CN)(Im)(TDHC’) were calculated to be 47.9 kcal/mol and 20.5 
kcal/mol, respectively, indicating that ligation of cyanide ion decreases the BDE of the Co–N(Im) bond.  
This is also supported by the higher pK1/2 value of rMb(CoIII(CN)(TDHC)) (Table 3-5).  Furthermore, it 
is noted that the methylation of Co(Im)(TDHC’) significantly reduces the BDE value of the Co–N(Im) 
bond (14.3 kcal/mol).   
The data listed in Table 3-6 indicate that the Co–N(Im) bond of Co(Im)(TDHC’)(X) lengthens as 
the BDE value of the Co–N(Im) bond decreases.  The elongation of the bond length of the Co–N(Im) 
which occurs upon binding of cyanide binding is supported by the X-ray crystal structure data (Figure  
3-10).7,23,24  In the case of rMb(CoIII(CH3)(TDHC)), similar elongation of the bond length of the 
Co–N(His93) would lead to the de-ligation of His93, which promotes the transmethylation in the 
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myoglobin matrix.11  Such ligation and de-ligation events should be also significant for methylcobalamin 
in the native enzyme to regulate the reactivity. 
 
 
 
Figure 3-9.  Chemical structures of the imidazole-coordinated (a) Co(TDHC’)(X) and (b) Co(corrin)(X) 
as models of Co(TDHC) and cobalamin, respectively.  X = X = OH2, CN– or CH3–. 
 
 
Table 3-6.  Bond-dissociation energy (BDE) of the Co–N(Im) bond and bond lengths of Co–X and 
Co–N(Im) bonds in CoIII(TDHC’)(Im)(X).a,b 
cobalt complex 
BDE of Co–N(Im) 
(kcal/mol) 
bond length (Å) 
Co–Xb Co–N(Im) 
CoIII(OH2)(Im)(TDHC’)c 47.9 2.08 1.90 
CoIII(CN)(Im)(TDHC’)c 20.5 1.85 2.08 
CoIII(CH3)(Im)(TDHC’)d 14.3 1.98 2.21 
aat the BP86/6-31G(d) level of theory. bX is the 6th ligand: X = OH2, CN– or CH3–. 
cThis work. dRef. 11. 
 
 
 
Figure 3-10.  Schematic representations for (a) DFT-optimized structure of CoIII(CN)(Im)(TDHC’), and 
crystal structures of (b) rMb(CoIII(CN)(TDHC)) and (c) cyano-nMb (PDB ID: 2JHO). 
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3-3.  Summary 
The author demonstrates that myoglobins reconstituted with aqua- and cyano-cobalt tetradehydrocorrins 
are appropriate for investigation as simplified cobalamin models.  It is of particular interest to evaluate 
the binding characteristics of axial ligands for Co(III) corrinoids.  13C NMR and IR studies of 
rMb(CoIII(CN)(TDHC)) indicate that the cyanide weakly interacts with CoIII(TDHC).  The σ-donation 
from the cyanide ion to CoIII(TDHC) is relatively weaker than that of cyanide-binding cobalamin.  
Furthermore, the large pK1/2 value of rMb(CoIII(CN)(TDHC)) suggests that cyanide binding weakens the 
Co–N(His93) bond strength.  In addition, the X-ray crystal structure analysis reveals that the 
Co–N(His93) bond length is slightly elongated.  The DFT calculations also clearly support the unique 
axial ligation; the Co–N(Im) bond is elongated and the BDE of Co–N(Im) is significantly decreased upon 
replacement of H2O with cyanide as an axial ligand.  Given these findings, it appears that the 
cyanide-binding species in Co(TDHC) is a transient structural model of methylcobalamin which promotes 
methyl group transfer to homocysteine in methionine synthase. 
 
3-4.  Experimental section 
Instruments 
UV-vis spectral measurements were carried out with a Shimadzu UV-3150 or UV-2550 double-beam 
spectrophotometer, or a Shimadzu BioSpec-nano spectrometer.  13C NMR spectra were collected on an 
Avance III (600 MHz) NMR spectrometer.  IR spectra were recorded with a JASCO FT/IR-6200 
spectrometer using the SL-2 demountable cell unit (optical path-length = 0.025 mm, Pier Optics Co., Ltd., 
Japan) with CaF2 windows.  ICP-OES (inductively coupled plasma optical emission spectroscopy) was 
performed with a Shimadzu ICPS-7510 emission spectrometer.  The pH measurements were made with 
an F-52 Horiba pH meter. 
 
Materials and methods. 
All reagents of the highest guaranteed grade available were obtained from commercial sources and were 
used as received unless otherwise indicated.  Distilled water was demineralized using a Barnstead 
NANOpure DIamondTM or Millipore Integral3 apparatus.  Synthesis of cobalt tetradehydrocorrin, 
Co(TDHC), was described in the author’s previous report.10  Native horse heart myoglobin, nMb, (Sigma 
Aldrich) was purified with a cation exchange CM-52 cellulose column.  The apoprotein was prepared 
according to Teale’s method.25  The reconstituted protein, rMb(CoII(TDHC)), was obtained by the 
conventional method.10  A co balt standard solution for ICP-OES was purchased from Wako Pure 
Chemical Industries. 
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Preparation of rMb(CoIII(OH2)(TDHC)) 
Into a solution of rMb(CoII(TDHC))10 (50 μM, 5 mL, 0.25 μmol) in 0.1 M potassium phosphate buffer at 
pH 7.0 was added a solution of K3[Fe(CN)6] (0.1 M, 0.25 mL, 25 μmol, 100 eq).  After equilibrating at 4 
ºC under aerobic conditions for 2 h, the protein was purified using a HiTrap desalting column (5 mL, GE 
Healthcare) with 0.1 M potassium phosphate buffer at pH 7.0.  The protein solution was stored in the 
dark at –80 ºC. UV-vis spectral data of the protein are shown in Table 3-1. 
 
Preparation of rMb(CoIII(CN)(TDHC)) 
Into a solution of rMb(CoII(TDHC)) (50 μM, 5 mL, 0.25 μmol) in 0.1 M potassium phosphate buffer at pH 
7.0 were added a solution of K3[Fe(CN)6] (0.1 M, 50 μL, 5 μmol, 20 eq) and a solution of KCN (50 mM, 
50 μL, 2.5 μmol, 10 eq).  After equilibrating at 4 ºC under aerobic conditions for 12 h, the protein was 
purified using a HiTrap desalting column (5 mL, GE Healthcare) with 0.1 M potassium phosphate buffer at 
pH 7.0. The protein solution was stored in the dark at –80 ºC.  UV-vis spectral data of the protein are 
shown in Table 3-1. ESI-TOF MS (negative mode, m/z): [M–7H+]7– calcd for C803H1241CoN215O222S2, 
2511.59; found, 2511.62.   
 
UV-vis spectral measurements of Co(TDHC) complexes without the protein matrix as control 
experiments 
Into a solution of CoII(TDHC) (10 μM, 20 mL, 0.2 μmol) in 0.1 M potassium phosphate buffer at pH 7.0 
was added a solution of K3[Fe(CN)6] (0.1 M, 0.2 mL, 20 μmol, 100 eq).  After equilibrating at 4 ºC under 
aerobic conditions for 2 h, the oxidized Co(III) species, CoIII(TDHC)L2 (L = H2O or OH–), was obtained.  
Subsequently, into the solution of CoIII(TDHC)L2 (10 μM, 5 mL, 0.05 μmol) was added a solution of 
imidazole (0.5 M, 10 μL, 5 μmol, 100 eq) to yield the imidazole-ligated species.  Into the solution of 
CoIII(TDHC)L2 (10 μM, 5 mL, 0.05 μmol) was added a solution of KCN (50 mM, 50 μL, 2.5 μmol, 50 eq) 
to yield the dicyano species, CoIII(CN)2(TDHC).  The UV-vis spectrum of each species was recorded at 
25 ˚C without any purification. The UV-vis spectral data are summarized in Table 3-1. 
 
Autoxidation of rMb(CoII(TDHC)) in the presence of KCN 
Into a solution of rMb(CoII(TDHC)) (50 μM, 1 mL, 0.05 μmol) in 0.1 M potassium phosphate buffer at pH 
7.0 was added a solution of KCN (50 mM, 10 μL, 0.5 μmol, 10 eq).  After equilibrating at 4 ºC under 
aerobic conditions for 12 h, the UV-vis spectrum of the solution was monitored.   
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Determination of pKa and pK1/2 values 
UV-vis spectra of rMb(CoIII(OH2)(TDHC)), rMb(CoIII(CN)(TDHC)), rMb(CoII(TDHC)) and nMb (10–40 
μM) in 0.1 M potassium phosphate buffer at 25 °C were measured under conditions of varying pH values 
which were adjusted by incremental addition of aqueous solutions of 1–12 M HCl or 10 M NaOH.  The 
pH values of the solution were recorded before and after each spectroscopic measurement.  The pKa and 
pK1/2 values were determined from the data which are fitted to the following Henderson-Hasselbach 
equation (eq 2) for a one proton transfer process,26 
 
                                                                  (2) 
 
where Z is absorbance at a certain pH; and Aacid and Aneutral are absorbances of the acid and neutral forms, 
respectively. 
 
Protein crystallization 
Crystallization of rMb(CoII(TDHC)) was performed at 25 ºC using the hanging-drop vapor-diffusion 
method.10  The protein drops were prepared by mixing of 5 μL of the protein solution (10 mg/mL) in 0.1 
M Tris-HCl buffer at pH 7.4 with 5 μL of a reservoir solution at pH 7.4 containing 3.4 M ammonium 
sulfate, 0.1 M Tris-HCl and 10% trehalose.  The obtained crystals were soaked in the reservoir solution 
containing K3[Fe(CN)6] (15.2 mM) to prepare the crystals of the aqua-Co(III) species.  A color change 
from dark red to green was observed within 10 days and the crystal was then fished and flash-cooled in a 
stream of N2 gas at 100 K.  To prepare the crystals of the cyano-Co(III) species, the crystals of 
rMb(CoII(TDHC)) were soaked in the reservoir solution containing 5 mM KCN and 117 mM K3[Fe(CN)6].  
A color change from dark red to green was observed within 20 min and the crystal was then fished and 
flash-cooled in a stream of N2 gas.   
 
Crystal structure determination and refinement 
X-ray diffraction data were collected at beamline BL44XU of SPring-8 (Harima, Japan).  The data were 
processed with the program HKL2000.27a  The structures were determined by the molecular replacement 
method using the program PHASER27b from the CCP4 program suite.27c  A crystal structure of horse heart 
myoglobin (Protein Data Bank (PDB) ID: 3WFT) was used as the search model.  Refinement was carried 
out using the program REFMAC.27d  The structures were visualized and modified using the program 
COOT.27e  Since the electron density of Co(TDHC) indicates that two enantiomers (1R,19R)- and 
(1S,19S)-TDHCs of Co(TDHC) exist in the heme pocket, the author assigned approximate RR:SS 
occupancy with a ratio of 35:65 in both proteins.  Data collection and refinement statistics are 
)p(pH
)p(pH
neutralacid
10+1
x10+
K
KAA
Z



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summarized in Table 3-7.   
 
Table 3-7.  Data collection and refinement statistics for the reconstituted myoglobins 
 rMb(CoIII(OH)(TDHC)) rMb(CoIII(CN)(TDHC)) 
PDB ID 5AZR 5AZQ 
Data collection   
X-ray source SPring-8 BL44XU SPring-8 BL44XU 
Detector Rayonix MX225HE Rayonix MX225HE 
Wavelength (Å) 0.90000 0.90000 
Resolution (Å) 
(outer shell) 
50 – 1.20 (1.24 – 1.20) 50 – 1.40 (1.45 – 1.40) 
Space group P21 P21 
Unit cell parameters (Å, 
deg.) 
a = 34.79, b = 28.84, c = 63.32,  
= 106.17 
a = 34.77, b = 28.81, c = 63.26,  = 
105.64 
Total reflections 136,063 85,185 
Unique reflections 37,167 23,585 
Completeness (%) 97.6 (97.5) 97.8 (95.5) 
Rsym
a 5.8 (42.8) 5.6 (37.6) 
I/σ(I) 20.4 (3.1) 22.6 (2.4) 
Refinement   
Resolution (Å) 50 – 1.20 50 – 1.40 
No. of reflections 35,357 22,308 
Rcryst / Rfree (%) 12.1 / 16.8 12.8 / 18.9 
Mean B-factor (Å2) 17.3 18.8 
No. of non-H atoms 1,476 1,456 
Bond lengths (Å) / angles 
(deg.) 
0.033 / 3.248 0.027 / 3.070 
aRsym = ΣhklΣi |Ii(hkl)  <I(hkl)>| / ΣhklΣiIi(hkl), where Ii(hkl) is the value of the ith measurement of the 
intensity of a reflection, <I(hkl)> is the mean value of the intensity of that reflection and the summation is 
over all measurements. 
 
 
NMR measurements of rMb(CoIII(CN)(TDHC)) 
Into a solution of rMb(CoII(TDHC)) (0.55 mM, 3 mL, 1.65 μmol) in 0.1 M potassium phosphate buffer at 
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pH 7.0 was added a solution of normal or 13C-enriched KCN (0.1 M, 33 μL, 3.3 μmol, 2 eq) and then the 
mixture was equilibrated at 4 ºC under aerobic conditions for 30 min.  After concentration to 0.8 mL 
using an Amicon Ultra-4 centrifugal filter (10 kDa) (GE Healthcare), the protein solution was passed 
through a HiTrap desalting column (GE Healthcare) equilibrated with 0.1 M potassium phosphate buffer at 
pH 7.0.  After addition of D2O (final concentration of D2O: 10%v/v), the solution was concentrated to 0.4 
mL and transferred to an NMR microtube (Shigemi Co., Ltd., Hachioji, Japan).  The 13C NMR 
measurements of the proteins were carried out at 5 ˚C over 2 days (65536 scans).  As the control 
experiments of the reconstituted proteins, CoIII(13CN)2(TDHC) was prepared by autoxidation of 
CoII(TDHC) (2 mM) in the same buffer containing K13CN (4 mM) under aerobic conditions. 
 
FT-IR measurements of rMb(CoIII(CN)(TDHC)) 
Each solution containing 13C-enriched or normal cyanide bound to the cobalt complex (ca. 6 mM) in 0.1 M 
potassium phosphate buffer at pH 7.0 was prepared.  A series of FT-IR spectra were accumulated (50 
scans) at 25 ºC with 4.0 cm–1 resolution.   
 
Relaxation analysis of cyanide binding 
In general, it is difficult to determine the affinity of cyanide for aqua-Co(III) complexes, because the 
ligand-exchange process is too slow to detect by conventional titrimetric measurements at 25 °C, pH 7.0 in 
the presence of KCN (10 μM).16  Thus, the binding constant of cyanide was determined by a relaxation 
analysis.16  Into a solution of rMb(CoIII(OH2)(TDHC)) (10 μM) in 0.1 M potassium phosphate buffer at 
pH 7.0 was added a solution of 0.20 M or 0.10 M KCN in the same buffer to the desired final 
concentrations of KCN (0.10, 0.50, 1.0, 1.5 and 2.0 mM) and then UV-vis spectra were recorded at 25 ºC 
for 20 min.  The concentrations of the cyanide ion were determined using the following 
Henderson-Hasselbach equation (eq 3) 
 
                                                         (3) 
 
where the pH and pKa values are 7.0 and 9.228 at 25 ˚C, respectively; C0 is the initial concentration of KCN.  
The spectral changes occurring over 20 min upon addition of KCN were observed.  The transient 
relaxation kinetics are represented by the following equation (eq 4), 
 
 rMb(CoIII(H2O)(TDHC)) + L          rMb(CoIII(L)(TDHC)) (4) 
 
where L denotes an exogenous ligand; kon and koff are rate constants for the association and dissociation of 
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L, respectively.  The observed rate constant kobs. is given by following equation (eq 5).16 
 kobs. = koff + kon[L]     (5) 
The binding constant of cyanide for rMb(CoIII(H2O)(TDHC)) was determined by following equation (eq. 
6), 
 K = kon/koff      (6) 
 
Computational chemistry 
The author used the Becke–Perdew (BP86)29 method implemented in the Gaussian 09 program.  For all 
atoms, the 6-31G(d) basis set was used.  This level of theory BP86/6-31G(d) serves as an appropriate 
platform to address the structural, electronic, and spectroscopic properties of cobalamin cofactors.30  All 
calculations were carried out in the gas phase.  As truncated models of Co(TDHC) and cobalamin, the 
author used Co(TDHC’) and Co(corrin), respectively, where all of the peripheral side chains in TDHC and 
corrin are replaced with hydrogen atoms for DFT calculations.11  The bond dissociation energies (BDEs) 
of the Co–N(Im) bonds of the Im-coordinated Co(III) complexes are defined by the following equation (eq 
7), 
BDE = E(CoIII(L)) + E(Im) – E(CoIII(Im)(L))          (7) 
 
where E(X) is the energy of the optimized structure of X; L and Im are exogenous axial ligand and 
imidazole, respectively; and CoIII(L) and CoIII(Im)(L) are Im-free and Im-coordinated Co(III) complexes 
which are coordinated by L, respectively. 
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Conclusion 
 
Methionine synthase, one of cobalamin-dependent methyltransferases, mediates an essential reaction of 
methyl group transfer using methylcobalamin as an organometallic cofactor in organisms.  However, the 
detailed mechanism which suggests the transmethylation in the enzyme matrix has not been understood 
completely, because of the complicated molecular structures of the cofactor and the protein matrix.  In the 
present study, the author has constructed and investigated the model system to reveal the reaction 
mechanism via the organometallic species possessing the unique reactivity in the enzyme matrix.  
Myoglobin reconstituted with a cobalt corrinoid as a newly-prepared model system provides the details of 
structure, reactivity and coordination behavior of the intermediates to understand the reaction mechanism.   
As an enzyme model, a cobalt corrinoid complex with a simple protein matrix was designed and 
prepared to clarify the coordination behavior of the Co(I) species, one of the important intermediates.  In 
the present work, the author chose cobalt tetradehydrocorrin (Co(TDHC)) as a model complex of 
cobalamin.  Next, the author employed myoglobin as a simple protein matrix with an axial histidine 
residue, which is similar to the cobalamin binding domain.  The model complex was inserted into the 
protein matrix by a conventional reconstitution method to obtain myoglobin reconstituted with 
CoII(TDHC), rMb(CoII(TDHC)).  UV-vis and EPR spectroscopies clearly show that the Co(II) species is 
coordinated by the His93 residue as an axial ligand.  Furthermore, the X-ray crystal structure of the 
rMb(CoII(TDHC)) reveals the penta-coordinated Co(II) complex with the His93 ligation.  Therefore, the 
reconstituted myoglobin can be regarded as a His-on model of methionine synthase.  The Co(II) species 
was then reduced with dithionite to yield the Co(I) species, rMb(CoI(TDHC)), which was characterized by 
UV-vis and EPR spectroscopies.  The Co(I) species was also prepared in the protein crystals by soaking 
the protein crystals of rMb(CoII(TDHC)) into the dithionite solution.  In the X-ray crystal structure, 
de-ligation of the His93 residue coordinated to the Co(II) species occurs to form the tetra-coordinated 
Co(I) species in the heme-binding pocket.   
To understand the reaction mechanism of the transmethylation occurring in methionine synthase, 
the model reactions by the reconstituted protein were investigated.  The Co(I) species reacted with methyl 
iodide to generate the CH3–Co(III) species in the myoglobin matrix, which is identified by UV-vis and 
EPR spectroscopies, and ESI mass spectrometry.  Since the organometallic species are not obtained in 
organic solvents, this result suggests that the axial coordination of the His93 residue stabilizes the 
methylated complex.  The theoretical calculations also support the stabilization of the methylated 
complex by the imidazole-ligation.  Furthermore, the author observed the intraprotein transmethylation in 
the heme pocket over 24 h at 25 ˚C.  The in source decay analysis by MALDI TOF MS indicates that the 
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methyl group on the cobalt center is transferred to the His64 residue in the heme pocket.  The NMR 
spectra of the peptide fragment containing the His64 residue prepared by trypsin-digestion of the 
methylated protein indicate that the methyl group is transferred to the Nɛ atom of the His64 residue via a 
heterolytic cleavage of the Co–C bond.  The HPLC analysis of the peptides shows the first-order reaction 
of the transmethylation.  The theoretical study suggests that the stepwise pathway via a His-off 
intermediate is more plausible than the concerted pathway for the transmethylation, indicating that the 
de-ligation of the His93 residue activates the methyl group.  The moderate coordination of His93 to the 
cobalt center in TDHC induces the transmethylation via the His-off species, because there is sufficient 
space to allow flipping of the imidazole ring in the proximal site.  These findings proposed that dynamic 
structural changes of the enzyme would likely promote de-ligation in the cobalamin-binding domain. 
Because of the difficulty for the characterization of the CH3–Co(III) species, the author prepared 
and investigated the aqua- and cyano-Co(III) species to understand the coordination behavior of the 
Co–N(His93) bond.  The X-ray crystal structures show that the hexa-coordinated aqua- and cyano-Co(III) 
species with the axial His93 ligation in the myoglobin matrix.  The X-ray crystallography and IR 
spectroscopy show the elongation of the Co–CN bond of the cyano-Co(III) species compared to 
cyanocobalamin.  This result is also supported the much lower affinity of cyanide for 
rMb(CoIII(OH2)(TDHC)) than that for aquacobalamin.  The acid titration and theoretical results for 
cyano-Co(III) species indicate the relatively weak Co–N(Im) bond.  The similar weak coordination of the 
histidine residue to the cobalt center is plausible in the CH3–Co(III) species due to higher σ-donation of the 
methyl group.  The theoretical calculations of the CH3–Co(III) species also suggest the elongation of the 
Co–N(Im) bond, which would lead to the transient formation of the His-off intermediate promoting the 
transmethylation in the myoglobin matrix.   
The author has developed myoglobin reconstituted with Co(TDHC) as an model of 
cobalamin-dependent methionine synthase.  The author’s model demonstrates the tetra-coordinated 
structure of the Co(I) species as an important intermediate and the model reactions of the transmethylation 
in the protein matrix.  The theoretical study supports the mechanism that the axial histidine ligation and 
the de-ligation are significantly effective for the stabilization and activation of the CH3–Co(III) species, 
respectively.  Furthermore, the investigation of the coordination behavior of the Co(III) species suggests 
that the protein matrix would provide the flexible ligation.  The present model system provides the 
understanding for the mechanism that the His-on/off switching controls the multi-step reactions in 
structurally complex cobalamin-dependent methionine synthase. These findings give an important insight 
into generating a new biocatalyst toward difficult alkylations of various substrates.   
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